One World Products (OWPC) 10-K 15 May 23 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2022	May 10, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2022
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	000-56151
Entity Registrant Name	ONE WORLD PRODUCTS, INC.
Entity Central Index Key	0001622244
Entity Tax Identification Number	61-1744826
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	6605 Grand Montecito Pkwy
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Las Vegas
Entity Address, State or Province	NV
Entity Address, Postal Zip Code	89149
City Area Code	(800)
Local Phone Number	605-3210
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 8,651,657
Entity Common Stock, Shares Outstanding		70,202,907
Documents Incorporated by Reference [Text Block]	None
ICFR Auditor Attestation Flag	false
Auditor Firm ID	2738
Auditor Name	M&K CPAS, PLLC
Auditor Location	Houston, TX

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 11,016	$ 119,678
Accounts receivable	12,355	19,880
Inventory	54,153	198,595
Other current assets	45,943	158,836
Total current assets	123,467	496,989
Other assets	179,927	147,194
Right-of-use assets	425,969
Security deposits	1,449,808	1,255,988
Fixed assets, net	988,536	1,003,013
Total Assets	3,167,707	2,903,184
Current liabilities:
Accounts payable	798,067	480,146
Accrued expenses	948,458	457,762
Deferred revenues	11,808	30,164
Dividends payable	137,843	98,920
Current portion of lease liabilities	86,235
Convertible notes payable, net of $-0- and $412,673 of debt discounts at December 31, 2022 and 2021, respectively	750,000	337,327
Notes payable, current maturities	145,524	119,274
Notes payable, related parties, current maturities	99,500
Total current liabilities	2,977,435	1,523,593
Long-term lease liability	341,680
Notes payable, long-term portion	700,000
Notes payable, related parties, long-term portion	200,000	200,000
Total Liabilities	4,219,115	1,723,593
Stockholders’ Equity (Deficit):
Preferred stock, $0.001 par value, 9,200,000 shares authorized; no shares issued and outstanding at December 31, 2022 and 2021, respectively
Common stock, $0.001 par value, 300,000,000 shares authorized; 67,202,907 and 65,599,565 shares issued and outstanding at December 31, 2022 and 2021, respectively	67,203	65,600
Additional paid-in capital	17,123,603	16,843,656
Subscriptions payable, consisting of -0- and 262,066 shares at December 31, 2022 and 2021, respectively		21,725
Accumulated other comprehensive loss	(50,699)	(64,347)
Accumulated (deficit)	(22,976,365)	(19,916,888)
Total Stockholders’ Equity (Deficit)	(5,836,258)	(3,050,254)
Total Liabilities and Stockholders’ Equity (Deficit)	3,167,707	2,903,184
Series A Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	702,330	652,330
Series B Convertible Preferred Stock [Member]
Current liabilities:
Convertible preferred stock value	$ 4,082,520	$ 3,577,515

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Convertible notes payable, debt discounts	$ 0	$ 412,673
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	9,200,000	9,200,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	67,202,907	65,599,565
Common stock, shares outstanding	67,202,907	65,599,565
Subscriptions payable, shares	0	262,066
Series A Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	500,000	500,000
Temporary equity, shares issued	70,233	65,233
Temporary equity, shares outstanding	70,233	65,233
Preferred stock, shares authorized	10,000,000
Series B Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	300,000	300,000
Temporary equity, shares issued	272,168	238,501
Temporary equity, shares outstanding	272,168	238,501

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues	$ 125,662	$ 38,264
Cost of goods sold	300,757	19,744
Gross profit (loss)	(175,095)	18,520
Operating expenses:
General and administrative	1,587,017	2,294,284
Professional fees	431,737	915,217
Depreciation expense	42,287	40,321
Total operating expenses	2,061,041	3,249,822
Operating loss	(2,236,136)	(3,231,302)
Other income (expense):
Sublease income	1,000	27,000
Loss on disposal of fixed assets	(9,041)	(71,487)
Gain on early extinguishment of lease	20,148
Gain on forgiveness of PPP loan	121,372
Interest income	38	2,358
Interest expense	(956,858)	(511,131)
Total other expense	(823,341)	(553,260)
Net loss	(3,059,477)	(3,784,562)
Other comprehensive loss:
Gain (loss) on foreign currency translation	13,648	(11,477)
Net other comprehensive loss	(3,045,829)	(3,796,039)
Series A convertible preferred stock declared ($0.60 per share)	(38,923)	(61,684)
Net loss attributable to common shareholders	$ (3,084,752)	$ (3,857,723)
Weighted average number of common shares outstanding - basic and diluted	66,191,644	60,600,548
Net loss per share - basic and diluted	$ (0.05)	$ (0.06)
Dividends declared per share of common stock	$ 0	$ 0

Consolidated Statements of Op_2

Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) - $ / shares	Dec. 31, 2022	Jan. 28, 2022	Dec. 31, 2021	Jul. 26, 2021
Purchase price per share		$ 0.50		$ 0.13
Series A Convertible Preferred Stock [Member]
Purchase price per share	$ 0.60		$ 0.60

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)	Preferred Stock [Member] Series A Convertible Preferred Stock [Member]	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Subscriptions Payable [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2020	$ 1,502,330		$ 53,085	$ 14,103,672	$ 75,000	$ (52,870)	$ (16,132,326)	$ (1,953,439)
Balance, shares at Dec. 31, 2020	150,233		53,085,305
Series B convertible preferred stock sold for cash to our CEO		$ 3,050,010
Series B convertible preferred stock sold for cash to our CEO, shares		203,334
Series B convertible preferred stock sold for cash		$ 527,505		(10)				(10)
Series B convertible preferred stock sold for cash, shares		35,167
Common stock sold for cash			$ 750	74,250	(75,000)
Common stock sold for cash, shares			750,000
Conversion of series A convertible preferred stock	$ (850,000)		$ 8,500	841,500				850,000
Conversion of series A convertible preferred stock, shares	(85,000)		8,500,000
Common stock issued for services			$ 955	111,075	21,725			133,755
Common stock issued for services, shares			954,260
Commitment shares issued pursuant to promissory note			$ 2,250	416,062				418,312
Commitment shares issued pursuant to promissory note, shares			2,250,000
Exercise of cashless options			$ 60	(60)
Exercise of cashless options, shares			60,000
Warrants issued as a debt discount				358,017				358,017
Amortization of common stock options issued for services				1,000,834				1,000,834
Series A convertible preferred stock dividends declared ($0.60 per share)				(61,684)				(61,684)
Loss on foreign currency translation						(11,477)		(11,477)
Net loss							(3,784,562)	(3,784,562)
Balance at Dec. 31, 2021	$ 652,330	$ 3,577,515	$ 65,600	16,843,656	21,725	(64,347)	(19,916,888)	(3,050,254)
Ending balance, shares at Dec. 31, 2021	65,233	238,501	65,599,565
Series B convertible preferred stock sold for cash		$ 300,000
Series B convertible preferred stock sold for cash, shares		20,000
Common stock issued for services			$ 1,603	154,250	(21,725)			134,128
Common stock issued for services, shares			1,603,342
Amortization of common stock options issued for services				164,620				164,620
Series A convertible preferred stock dividends declared ($0.60 per share)				(38,923)				(38,923)
Loss on foreign currency translation						13,648		13,648
Net loss							(3,059,477)	(3,059,477)
Series A convertible preferred stock sold for cash	$ 50,000
Series A convertible preferred stock sold for cash, shares	5,000
Series B convertible preferred stock issued as commitment fee on ELOC		$ 205,005
Series B convertible preferred stock issued as commitment fee on ELOC, shares		13,667
Balance at Dec. 31, 2022	$ 702,330	$ 4,082,520	$ 67,203	$ 17,123,603		$ (50,699)	$ (22,976,365)	$ (5,836,258)
Ending balance, shares at Dec. 31, 2022	70,233	272,168	67,202,907

Consolidated Statement of Sto_2

Consolidated Statement of Stockholders' Equity (Deficit) (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Series A Convertible Preferred Stock [Member]
Share issued price per share	$ 0.60	$ 0.60

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net loss	$ (3,059,477)	$ (3,784,562)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debts expense		2,062
Depreciation and amortization expense	42,287	40,321
Loss on disposal of fixed assets	9,041	71,487
Gain on early extinguishment of lease	(20,148)
Gain on forgiveness of PPP loan	(121,372)
Amortization of debt discounts	412,673	456,656
Stock-based compensation	339,133	133,755
Amortization of options issued for services	164,620	1,000,834
Decrease (increase) in assets:
Accounts receivable	7,525	(16,306)
Inventory	144,442	68,557
Other current assets	112,893	(187,119)
Other assets	(32,733)
Right-of-use assets	118,347	195,029
Security deposits	(193,820)	(1,190,874)
Increase (decrease) in liabilities:
Accounts payable	317,921	(254,408)
Accrued expenses	492,794	(92,773)
Deferred revenues	(18,356)	30,164
Lease liability	(96,253)	(201,525)
Net cash used in operating activities	(1,380,483)	(3,728,702)
Cash flows from investing activities
Proceeds received on disposal of fixed assets	6,350	5,125
Purchase of fixed assets	(43,201)	(393,126)
Net cash used in investing activities	(36,851)	(388,001)
Cash flows from financing activities
Proceeds from convertible note payable	750,000
Repayment of convertible note payable	(750,000)
Proceeds from notes payable	868,081	1,147,000
Repayment of notes payable		(505,567)
Proceeds from notes payable, related parties	99,500
Proceeds from sale of preferred and common stock	350,000	3,577,505
Net cash provided by financing activities	1,317,581	4,218,938
Effect of exchange rate changes on cash	(8,909)	(11,477)
Net increase (decrease) in cash	(108,662)	90,758
Cash - beginning	119,678	28,920
Cash - ending	11,016	119,678
Supplemental disclosures:
Interest paid	117,112	48,252
Income taxes paid
Non-cash investing and financing transactions:
Initial recognition of right-of-use assets and lease liabilities	1,962,998
Cost of preferred shares exchanged for conversion to common stock		850,000
Value of commitment shares issued as a debt discount		418,312
Value of warrants issued as a debt discount		358,017
Dividends payable	38,923	61,684
Par value of cashless exercise of common stock options		$ 60

Nature of Business and Signific

Nature of Business and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Business and Significant Accounting Policies	Note 1 – Nature of Business and Significant Accounting Policies Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, One World Pharma, Inc. (“One World Pharma”) entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian company (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP Colombia. OWP Colombia is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). We plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. We have been generating revenue from the sale of our seeds since the second quarter of 2020. During the first quarter of 2022, we made payments of approximately $ 1,400,000 5 Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2022: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc (1) Nevada Parent OWP Ventures, Inc (2) Delaware Subsidiary One World Pharma S.A.S (3) Colombia Subsidiary Colombian Hope, S.A.S (4) Colombia Subsidiary Agrobase, S.A.S (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its production efforts are within Popayán, Colombia. Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings. Foreign Currency Translation The functional currency of the Company is Columbian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods. Comprehensive Income The Company has adopted ASC 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows: - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement. The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 not Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Fixed Assets Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy: Schedule of Estimated Useful Lives of Fixed Assets Buildings 15 Office equipment 5 Furniture and fixtures 7 Equipment and machinery 7 Leasehold improvements Term of lease Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extended the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations. Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s sales to date have primarily consisted of the sale of seeds. These sales include multi-element arrangements whereby the Company collects 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company has a right of first refusal to purchase products resulting from the harvest. At December 31, 2022, the Company had $ 11,808 6,655 Advertising Costs The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $ 80,498 137,915 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended December 31, 2022 and 2021, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share. Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance. Income Taxes The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not. Uncertain Tax Positions In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities. The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions. Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In October 2021, the FASB issued ASU 2021-08 , Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share Debt – Modifications and Extinguishments Compensation and Derivatives and Hedging – Contracts in Entity’s Own Equity Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity Classified Written Call Options In March 2020, the FASB issued ASU 2020-04 establishing Topic 848, Reference Rate Reform In August 2020, the FASB issued ASU No. 2020-06, Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2020-06 has not had a material impact on the Company’s financial statements or related disclosures. There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2 – Going Concern As shown in the accompanying financial statements, the Company had $ 2,853,968 22,976,365 The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to the Company’s ability to continue as a going concern. These financial statements also do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 3 – Related Party Transactions Expense Reimbursements Owed to Officers and Directors As of December 31, 2022, the Company owed a total of $ 65,382 2,505 Debt Repayments, Related Party On October 18, 2021, the Company repaid a total of $ 52,918 50,000 2,918 On September 15, 2021, the Company repaid a total of $ 130,610 125,000 5,610 On March 29, 2021, the Company repaid a total of $ 27,201 26,000 1,201 Series B Preferred Stock Sales On February 7, 2021, the Company and ISIAH International, LLC (“ISIAH International”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) under which ISIAH International agreed to purchase from the Company, on the dates provided for in the Purchase Agreement, an aggregate of 200,000 20,000,000 15 3 15 0.15 200,000 Schedule of Agreement to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000 On various dates in May, 2021, the Company also received total proceeds of $ 50,010 3,334 15 Common Stock Issued for Services On January 1, 2021, the Company awarded options to purchase 5,500,000 0.13 ten year 2,750,000 2,750,000 250,000 192 0.1174 645,624 117,388 410,853 117,383 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS On January 1, 2021, the Company awarded options to purchase 350,000 0.13 ten year 192 0.1170 40,943 40,943

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2022
Investments, All Other Investments [Abstract]
Fair Value of Financial Instruments	Note 4 – Fair Value of Financial Instruments Under FASB ASC 820-10-5, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value. The Company has certain financial instruments that must be measured under the new fair value standard. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs). Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balances sheet as of December 31, 2022 and 2021: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2022 Level 1 Level 2 Level 3 Assets Cash $ 11,016 $ - $ - Right-of-use asset - - 425,969 Total assets 11,016 - 425,969 Liabilities Lease liabilities - 427,915 Convertible notes payable, net of $412,673 of debt discounts - 337,327 - Convertible notes payable - 750,000 - Notes payable - 845,524 - Notes payable, related parties - 299,500 - Total liabilities - (1,895,024 ) (427,915 ) Total assets and liabilities $ 11,016 $ (1,895,024 ) $ (1,946 ) Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2021 Level 1 Level 2 Level 3 Assets Cash $ 119,678 $ - $ - Total assets 119,678 - - Liabilities Convertible notes payable, net of $ 412,673 - 337,327 - Notes payable - 119,274 - Notes payable, related parties - 200,000 - Total liabilities - (656,601 ) - Total assets and liabilities $ 119,678 $ (656,601 ) $ - There were no transfers of financial assets or liabilities between Level 1 and Level 2 inputs for the years ended December 31, 2022 or 2021.

Major Customers and Accounts Re

Major Customers and Accounts Receivable	12 Months Ended
	Dec. 31, 2022
Major Customers And Accounts Receivable
Major Customers and Accounts Receivable	Note 5 – Major Customers and Accounts Receivable The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: For the year ended December 31, 2022, no customers accounted for more than 10% 60% At December 31, 2022 and 2021, one customer accounted for 67% 75% ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Inventory

Inventory	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventory	Note 6 – Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts. Inventory consisted of the following at December 31, 2022 and 2021, respectively. Schedule of Inventory December 31, December 31, 2022 2021 Raw materials $ 18,580 $ 31,233 Work in progress 1,464 81,182 Finished goods 80,858 108,246 Inventory gross 100,902 220,661 Less obsolescence (46,749 ) (22,066 ) Total inventory $ 54,153 $ 198,595

Other Current Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Current Assets	Note 7 – Other Current Assets Other current assets included the following as of December 31, 2022 and 2021, respectively: Schedule of Other Current Assets December 31, December 31, 2022 2021 Prepaid expenses $ 39,288 $ 29,366 Deferred cost of goods sold 6,655 19,470 Other receivables - 110,000 Total $ 45,943 $ 158,836

Other Assets

Other Assets	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other Assets	Note 8 – Other Assets Other assets consist entirely of a $ 179,927 147,194

Security Deposits

Security Deposits	12 Months Ended
	Dec. 31, 2022
Security Deposits
Security Deposits	Note 9 – Security Deposits Security deposits included the following as of December 31, 2022 and 2021, respectively: Schedule of Security Deposits December 31, December 31, 2022 2021 Utility deposits $ - $ 1,090 Refundable deposit on equipment purchase 50,000 50,000 Down payment on distillation equipment 1,399,413 1,155,000 Security deposits on leases held in Colombia 395 35,869 Security deposit on office lease - 14,029 Security deposits $ 1,449,808 $ 1,255,988 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Fixed Assets

Fixed Assets	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Fixed Assets	Note 10 – Fixed Assets Fixed assets consist of the following at December 31, 2022 and 2021, respectively: Schedule of Fixed Assets December 31, December 31, 2022 2021 Land $ 138,248 $ 138,248 Buildings 473,971 473,971 Office equipment 30,902 56,502 Furniture and fixtures 6,495 34,409 Equipment and machinery 423,547 383,829 Fixed assets, gross 1,073,163 1,086,959 Less: accumulated depreciation (84,627 ) (83,946 ) Total $ 988,536 $ 1,003,013 On August 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., sold its office furniture and equipment with a net book value of $ 15,391 6,350 9,041 On November 30, 2021, the Company disposed of a building that was damaged in a storm at the Popayán farm. No 53,925 On July 27, 2021, the Company sold a truck previously used at the Popayán farm. The Company received proceeds of $ 5,125 2,064 On July 1, 2021, the Company disposed of equipment used at the Popayán farm that is no longer in service. No 15,498 Depreciation and amortization expense totaled $ 42,287 40,321

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Accrued Expenses	Note 11 – Accrued Expenses Accrued expenses consisted of the following at December 31, 2022 and 2021, respectively: Schedule of Accrued Expenses December 31, December 31, 2022 2021 Accrued payroll $ 613,569 $ 261,044 Accrued withholding taxes and employee benefits 31,632 9,162 Accrued ICA fees and contributions 167,037 129,856 Accrued interest 136,220 57,700 Accrued expenses $ 948,458 $ 457,762

Deferred Revenues

Deferred Revenues	12 Months Ended
	Dec. 31, 2022
Deferred Revenues
Deferred Revenues	Note 12 – Deferred Revenues Arrangements with customers include multiple deliverables, consisting of an initial delivery of seeds and a contingent portion of the sale that is dependent on the customers future harvest of the seeds. Deferred revenues associated with these multiple-element arrangements were $ 11,808 30,164 6,655 19,470 5,153 10,964 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Leases

Leases	12 Months Ended
	Dec. 31, 2022
Leases
Leases	Note 13 – Leases The Company leased its 12,400 57,339,000 15,290 7,700 20,148 On October 1, 2022, the Company entered into a five-year non-cancelable property lease, with an automatic five year extension, for a new extraction facility with combined office space, at a monthly lease term of 29,000,000 6,300 2% The Company also leases a residential premise under a non-cancelable real property lease agreement that commenced on September 1, 2021 and expires on August 31, 2024, at a monthly lease term of 3,800,000 1,013 3% The Company leases another residential premise under a non-cancelable real property lease agreement that commenced on June 1, 2022 and expires on May 30, 2024, at a monthly lease term of 1,900,000 507 8% In addition, the Company leases its corporate offices and operational facility in Colombia under short-term non-cancelable real property lease agreements that expire within a year. The Company doesn’t have any other office or equipment leases that would require capitalization. The office lease contains provisions requiring payment of property taxes, utilities, insurance, maintenance and other occupancy costs applicable to the leased premise. In the locations in which it is economically feasible to continue to operate, management expects to enter into a new lease upon expiration. The extraction facility lease contained provisions requiring payment of property taxes, utilities, insurance, maintenance and other occupancy costs applicable to the leased premise. As the Company’s leases do not provide implicit discount rates, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The components of lease expense were as follows: Schedule of Components of Lease Expense 2022 2021 For the Year Ended December 31, 2022 2021 Operating lease cost: Amortization of right-of-use assets $ 114,907 $ 87,276 Interest on lease liabilities 83,702 3,035 Lease payments on short term leases 23,811 - Total operating lease cost $ 222,420 $ 90,311 Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases December 31, December 31, 2022 2021 Operating lease: Operating lease assets $ 425,969 $ - Current portion of operating lease liabilities $ 86,235 - Noncurrent operating lease liabilities 341,680 - Total operating lease liability $ 427,915 $ - Weighted average remaining lease term: Operating leases 4.25 - Weighted average discount rate: Operating lease 6.75 % - ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Supplemental cash flow and other information related to operating leases was as follows: Schedule of Supplemental Cash Flow Related to Operating Leases 2022 2021 For the Year Ended December 31, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 96,253 $ 201,525 Early extinguishment of lease: Lease liability terminated $ 1,438,830 $ - Right-of use asset terminated (1,418,682 ) - Gain on early extinguishment of lease $ 20,148 $ - Leased assets obtained in exchange for lease liabilities: Total operating lease liabilities $ 1,962,998 $ - Our anticipated future lease commitments on a calendar year basis in US dollars, excluding common area maintenance fees, under non-cancelable operating leases are as follows: Schedule of Operating Lease Liability Maturity Minimum Year Ending Lease December 31, Commitments 2023 $ 112,508 2024 107,632 2025 99,186 2026 102,162 2027 78,336 Total future minimum lease liabilities $ 499,824

Convertible Note Payable

Convertible Note Payable	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Convertible Note Payable	Note 14 – Convertible Note Payable Convertible note payable consists of the following at December 31, 2022 and 2021, respectively: Schedule of Convertible Note Payable December 31, December 31, 2022 2021 On September 27, 2022, $ 750,000 $ - On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 8 15 $ 750,000 $ - On September 24, 2021, the Company completed the sale of a (i) Promissory Note in the principal amount of $ 750,000 three 1,500,000 0.25 three 2,000,000 0.50 705,000 197 0.1053 0.1001 358,017 678,750 45,000 15,000 11,250 The Note matures on September 24, 2022 8 20 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 250,000 1,250,000 150,062 The obligations of the Company to AJB Capital under the Note and the Purchase Agreement are secured by a lien on the Company’s assets pursuant to a Security Agreement between the Company and AJB Capital. The note was repaid on September 27, 2022. $ - $ 750,000 Total convertible notes payable 750,000 750,000 Less: unamortized debt discounts - 412,673 Convertible note payable, net of discounts $ 750,000 $ 337,327 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The Company recognized debt discounts for the years ended December 31, 2022 and 2021, as follows: Schedule of Convertible Debt Discounts December 31, December 31, 2022 2021 Fair value of 3,250,000 $ 106,894 $ 418,312 Fair value of warrants to purchase 3,500,000 255,026 358,017 Original issue discounts 32,055 53,700 Legal and brokerage fees 18,698 39,300 Total debt discounts 412,673 869,329 Amortization of debt discounts 412,673 456,656 Unamortized debt discounts $ - $ 412,673 The aggregate debt discounts of $ 869,329 412,673 456,656 The convertible note limits the maximum number of shares that can be owned by the note holder as a result of the conversions to common stock to 4.99% The Company recorded interest expense pursuant to the stated interest rates on the convertible notes in the amount of $ 59,023 36,243 412,673 456,656 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2022
Notes Payable
Notes Payable	Note 15 – Notes Payable Notes payable consists of the following at December 31, 2022 and 2021, respectively: Schedule of Notes Payable December 31, December 31, 2022 2021 On September 15, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 55,488,000 12,243 70,000,000 15,445 4% 3,202 893 $ 14,552 $ - On June 17, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 230,400,000 55,821 240,000,000 58,147 4% 2,326 8,253 49,894 - On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 January 1, 2024 8% 100,000 - On May 31, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 314,640,000 76,231 360,000,000 87,220 2.1% 10,990 12,380 74,841 - On May 30, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 20,000,000 4,846 688 4,158 - On April 29, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 10,000,000 2,423 344 2,079 - On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 January 1, 2024 8% 400,000 - On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 January 1, 2024 8% 200,000 - On May 4, 2020, the Company, through its wholly-owned subsidiary OWP Ventures, Inc., borrowed $ 119,274 1.00% May 4, 2022 40% 121,372 119,274 2,098 February 11, 2022 - 119,274 Total notes payable 845,524 119,274 Less: current maturities 145,524 119,274 Notes payable, long-term portion $ 700,000 $ - The Company recorded interest expense in the amount of $ 85,653 18,945 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Notes Payable, Related Party

Notes Payable, Related Party	12 Months Ended
	Dec. 31, 2022
Notes Payable Related Party
Notes Payable, Related Party	Note 16 – Notes Payable, Related Party Notes payable, related party, consists of the following at December 31, 2022 and 2021, respectively: Schedule of Notes Payable Related Party December 31, December 31, 2022 2021 On August 5, 2022, the Company received an advance of $ 50,000 6 $ 50,000 $ - On August 2, 2022, the Company received an advance of $ 4,500 6 4,500 - On July 7, 2022, the Company received an advance of $ 5,000 6 5,000 - On June 3, 2022, the Company received an advance of $ 10,000 6 10,000 - On May 5, 2022, the Company received an advance of $ 10,000 6 10,000 - On May 5, 2022, the Company received an advance of $ 20,000 6 20,000 - On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 200,000 200,000 Total notes payable. related party 299,500 200,000 Less: current maturities 99,500 - Notes payable, related party, long-term portion $ 200,000 $ 200,000 The Company recorded interest expense pursuant to the stated interest rates on the notes payable, related party, in the amount of $ 19,127 9,729 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The Company recognized interest expense for the year ended December 31, 2022 and 2021, respectively, as follows: Schedule of Interest Expenses December 31, December 31, 2022 2021 Interest on convertible notes $ 59,023 $ 17,260 Interest on notes payable 85,653 18,945 Interest on notes payable, related parties 19,127 9,729 Amortization of debt discounts on convertible notes 50,753 42,247 Amortization of debt discounts on convertible notes, common stock 106,894 311,418 Amortization of debt discounts on convertible notes, warrants 255,026 102,991 Finance cost on equity line of credit, issuances of series B preferred stock 205,005 - Finance cost on equity line of credit, issuances of common stock 134,128 - Finance cost on equity line of credit 30,000 - Interest on accounts payable 11,249 8,541 Total interest expense $ 956,858 $ 511,131

Convertible Preferred Stock

Convertible Preferred Stock	12 Months Ended
	Dec. 31, 2022
Convertible Preferred Stock
Convertible Preferred Stock	Note 17 – Convertible Preferred Stock Preferred Stock The Company has 10,000,000 0.001 500,000 300,000 The Series A Preferred Stock accrues dividends at the rate of 6 70,233 272,168 10 15 The Series A and B Preferred Stock have been classified outside of permanent equity and liabilities. the Series A Preferred Stock embodies conditional obligations that the Company may settle by issuing a variable number of equity shares, and in both the Series A and B Preferred Stock, monetary value of the obligation is based on a fixed monetary amount known at inception. Series A Preferred Stock Sales On various dates between December 20, 2022 and December 21, 2022, the Company received total proceeds of $ 50,000 5,000 5,000 five 500,000 0.25 Series A Preferred Stock Conversions On November 15, 2021, a shareholder converted 30,000 3,000,000 On April 6, 2021, a shareholder converted 30,000 shares of Series A Preferred Stock into 3,000,000 On March 24, 2021, a shareholder converted 10,000 1,000,000 On January 26, 2021, a shareholder converted 5,000 500,000 On January 12, 2021, a shareholder converted 10,000 1,000,000 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Preferred Stock Dividends The Series A Preferred Stock accrues dividends at the rate of 6 38,923 61,684 137,843 Series B Preferred Stock Sales On September 1, 2022, the Company and Tysadco Partners, LLC (“Tysadco”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) under which Tysadco agreed to purchase from the Company, 20,000 15 300,000 10,000 150,000 10,000 150,000 15,000 13,667 205,005 On February 7, 2021, the Company and ISIAH International entered into a Securities Purchase Agreement under which ISIAH International agreed to purchase from the Company, on the dates provided for in the Purchase Agreement, an aggregate of 200,000 20,000,000 15 3 15 0.15 200,000 Schedule to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000 In addition to the shares sold to ISIAH International, the Company received total proceeds of $ 527,520 35,167 15 50,010 3,334 15

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 18 – Commitments and Contingencies Equity Line of Credit On September 1, 2022, the Company entered into a Purchase Agreement (the “ELOC Purchase Agreement”) with Tysadco. Pursuant to the ELOC Purchase Agreement, Tysadco has agreed to purchase from the Company, from time to time upon delivery by the Company to Tysadco of “Request Notices,” and subject to the other terms and conditions set forth in the ELOC Purchase Agreement, up to an aggregate of $ 10,000,000 The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS In connection with the ELOC Purchase Agreement, the Company entered into a Registration Rights Agreement with Tysadco under which the Company agreed to file a registration statement with the Securities and Exchange Commission covering the shares of common stock issuable under the ELOC Purchase Agreement and conversion of the Commitment Fee Shares (the “Registration Rights Agreement”). There have not been any advances on this arrangement to date. Commitment for the Sale of Series B Preferred Stock On October 3, 2022, the Company and ISIAH International, LLC (“ISIAH International”), an entity in which the Company’s CEO, Isiah L. Thomas, III, is the sole member, entered into a securities purchase agreement under which ISIAH International has agreed to purchase from the Company an aggregate of 33,333 3,333,300 499,995

Stockholders_ Equity

Stockholders’ Equity	12 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Stockholders’ Equity	Note 19 – Stockholders’ Equity Preferred Stock The Company has 10,000,000 0.001 500,000 300,000 Common Stock The Company is authorized to issue an aggregate of 300,000,000 0.001 67,202,907 Common Stock Issued on Subscriptions Payable On March 29, 2022, the Company issued 262,066 Common Stock Issued as a Promissory Note Commitment As disclosed in Note 14 above, the Company paid a commitment fee to AJB Capital of $ 250,000 1,250,000 150,062 106,894 43,168 1,341,276 fair value of the shares was $ 134,128 Also, as disclosed in Note 14 above, the Company paid a commitment fee to AJB Capital of $ 200,000 2,000,000 268,250 268,250 1.00 Common Stock Options Exercised On July 26, 2021, a total of 60,000 125,000 0.13 Common Stock Issued for Services, Employees and Consultants On May 25, 2021, the Company awarded a total of 50,000 The aggregate fair value of the shares was $ 8,500 On May 12, 2021, the Company entered into a Settlement Agreement with COR. Pursuant to the Settlement Agreement, the Company issued COR 118,150 The fair value of the shares was $ 29,538 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS On June 1, 2021, the Company entered into a new agreement with COR and issued another 112,528 The fair value of the shares was $ 18,758 262,066 The fair value of the shares was $ 21,725 Common Stock Issued for Services, Officers and Directors On December 31, 2021, the Company issued 673,582 The aggregate fair value of the shares was $ 55,234

Common Stock Options

Common Stock Options	12 Months Ended
	Dec. 31, 2022
Common Stock Options
Common Stock Options	Note 20 – Common Stock Options Stock Incentive Plan On February 12, 2020, the Company’s stockholders approved our 2019 Stock Incentive Plan (the “2019 Plan”), which had been adopted by the Company’s Board of Directors (the “Board”) as of December 10, 2019. The 2019 Plan provides for the issuance of up to 10,000,000 Common Stock Options Issued for Services On May 28, 2021, the Company awarded options to purchase 1,000,000 0.1782 ten year 500,000 500,000 250,000 183 0.1719 171,949 171,949 On May 25, 2021, the Company awarded options to purchase an aggregate 425,000 0.17 ten year 183 0.1653 70,269 35,132 20,493 14,644 On January 1, 2021, the Company awarded options to purchase 5,500,000 0.13 ten year 2,750,000 2,750,000 250,000 192 0.1174 645,624 117,388 410,853 117,383 On January 1, 2021, the Company awarded options to purchase 350,000 0.13 ten year 192 0.1170 40,943 40,943 On January 1, 2021, the Company awarded options to purchase 475,000 0.13 ten year 192 0.1170 55,565 55,565 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS On January 1, 2021, the Company awarded options to purchase an aggregate 1,842,000 0.13 ten year 192 0.1170 215,475 215,475 Common Stock Options Exercised On July 26, 2021, a total of 60,000 125,000 0.13 Common Stock Options Expired On January 28, 2022, options to purchase a total of 500,000 0.50 The following is a summary of information about the Stock Options outstanding at December 31, 2022. Schedule of Option Exercise Price Range Shares Underlying Shares Underlying Options Outstanding Options Exercisable Weighted Shares Average Weighted Shares Weighted Underlying Remaining Average Underlying Average Range of Options Contractual Exercise Options Exercise Exercise Prices Outstanding Life Price Exercisable Price $ 0.13 0.56 10,242,000 8.05 $ 0.15 9,113,528 $ 0.15 The following is a summary of activity of outstanding stock options: Schedule of Option Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2020 1,275,000 $ 0.36 Options granted 9,592,000 0.14 Options exercised (125,000 ) (0.13 ) Balance, December 31, 2021 10,742,000 0.16 Options granted - - Options expired (500,000 ) (0.50 ) Balance, December 31, 2022 10,242,000 $ 0.15 Exercisable, December 31, 2022 9,113,528 $ 0.15

Common Stock Warrants

Common Stock Warrants	12 Months Ended
	Dec. 31, 2022
Common Stock Warrants
Common Stock Warrants	Note 21 – Common Stock Warrants Warrants to purchase a total of 11,511,650 On December 21, 2022, the Company received proceeds of $ 50,000 2,500 2,500 five 250,000 0.25 157 0.0699 17,468 On December 20, 2022, the Company received proceeds of $ 50,000 2,500 2,500 five 250,000 0.25 157 0.07 17,499 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The following is a summary of information about our warrants to purchase common stock outstanding at December 31, 2022. Schedule of Warrants to Purchase Common Stock Outstanding Shares Underlying Warrants Outstanding Shares Underlying Warrants Exercisable Range of Exercise Prices Shares Underlying Warrants Outstanding Weighted Average Remaining Contractual Life Weighted Average Exercise Price Shares Underlying Warrants Exercisable Weighted Average Exercise Price $ 0.25 0.50 11,511,650 2.43 $ 0.25 0.50 11,511,650 $ 0.25 0.50 The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan: Schedule of Fair value Assumption of Warrants December 31, December 31, 2022 2021 Average risk-free interest rates 3.79 % 0.47 % Average expected life (in years) 5.00 3.00 Volatility 157 % 197 % The weighted average fair value of warrants granted with exercise prices at the current fair value of the underlying stock was approximately $ 0.29 0.10 The following is a summary of activity of outstanding common stock warrants: Schedule of Warrants Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2020 7,511,650 $ 0.25 Warrants granted 3,500,000 0.39 Balance, December 31, 2021 11,011,650 0.30 Warrants granted 500,000 0.25 Balance, December 31, 2022 11,511,650 $ 0.29 Exercisable, December 31, 2022 11,511,650 $ 0.29

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Tax	Note 22 - Income Tax The Company accounts for income taxes under FASB ASC 740-10, which requires use of the liability method. FASB ASC 740-10-25 provides that deferred tax assets and liabilities are recorded based on the differences between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes, referred to as temporary differences. For the years ended December 31, 2022 and 2021, the Company incurred a net operating loss and, accordingly, no provision for income taxes has been recorded. In addition, no benefit for income taxes has been recorded due to the uncertainty of the realization of any tax assets. At December 31, 2022, the Company had approximately $ 9,285,000 The net operating loss carry forwards, if not utilized, will begin to expire in 2025 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The provision (benefit) for income taxes for the years ended December 31, 2022 and 2021 were assuming a 21% effective tax rate. The effective income tax rate for the years ended December 31, 2022 and 2021 consisted of the following: Schedule of Effective Income Tax Rate 2022 2021 December 31, 2022 2021 Federal statutory income tax rate 21 % 21 % State income taxes - % - Change in valuation allowance (21 %) (21 %) Net effective income tax rate - - The components of the Company’s deferred tax asset are as follows: Schedule of Deferred Tax Asset 2022 2021 December 31, 2022 2021 Deferred tax assets: Net operating loss carry forwards $ 1,950,000 $ 1,535,000 Net deferred tax assets before valuation allowance $ 1,950,000 $ 1,535,000 Less: Valuation allowance (1,950,000 ) (1,535,000 ) Net deferred tax assets $ - $ - Based on the available objective evidence, including the Company’s history of its loss, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company provided for a full valuation allowance against its net deferred tax assets at December 31, 2022 and 2021, respectively. In accordance with FASB ASC 740, the Company has evaluated its tax positions and determined there are no uncertain tax positions.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 23 – Subsequent Events Series A Preferred Stock Sales On various dates between January 4, 2023 and April 3, 2023, the Company received total proceeds of $ 250,000 from the sale of 25,000 units, consisting in the aggregate of 25,000 shares of series A preferred stock and five -year warrants to purchase an aggregate 2,500,000 shares of common stock at an exercise price of $ 0.25 Common Stock Sales On February 14, 2023, the Company sold 3,000,000 0.10 300,000 Common Stock Issued for Services, Consultants On January 1, 2023, the Company issued 4,500 The fair value of the shares was $ 45,000

Nature of Business and Signif_2

Nature of Business and Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Nature of Business	Nature of Business One World Products, Inc. (the “Company,” “we,” “our” or “us”) was incorporated in Nevada on September 2, 2014. On February 21, 2019, One World Pharma, Inc. (“One World Pharma”) entered into an Agreement and Plan of Merger with OWP Merger Subsidiary, Inc., our wholly-owned subsidiary, and OWP Ventures, Inc. (“OWP Ventures”), which is the parent company of One World Pharma SAS, a Colombian company (“OWP Colombia”). Pursuant to the Merger Agreement, we acquired OWP Ventures (and indirectly, OWP Colombia) by the merger of OWP Merger Subsidiary with and into OWP Ventures, with OWP Ventures being the surviving entity as our wholly-owned subsidiary (the “Merger”). As a result of the Merger (a) holders of the outstanding capital stock of OWP Ventures received an aggregate of 39,475,398 825,000 0.50 825,000 0.50 300,000 0.424 875,000 OWP Ventures is a holding company formed in Delaware on March 27, 2018 to enter and support the cannabis industry, and on May 30, 2018, it acquired OWP Colombia. OWP Colombia is a licensed cannabis cultivation, production and distribution (export) company located in Popayán, Colombia (nearest major city is Cali). We plan to be a producer of raw cannabis and hemp plant ingredients for both medical and industrial uses across the globe. We have received licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific and industrial purposes. Specifically, we are one of the few companies in Colombia to receive all four licenses, including seed use, cultivation of non-psychoactive cannabis, cultivation of psychoactive cannabis, and manufacturing allowing for extraction and export. Currently, we own approximately 30 acres and have a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, we have entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under which they will cultivate cannabis on up to approximately 140 acres of land using our seeds and propagation techniques, and sell their harvested products to us on an exclusive basis. We began harvesting cannabis in the first quarter of 2019 for the purpose of further research and development activities, quality control testing and extraction. We have been generating revenue from the sale of our seeds since the second quarter of 2020. During the first quarter of 2022, we made payments of approximately $ 1,400,000 5
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission (“SEC”). All references to Generally Accepted Accounting Principles (“GAAP”) are in accordance with The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and the Hierarchy of Generally Accepted Accounting Principles. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2022: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc (1) Nevada Parent OWP Ventures, Inc (2) Delaware Subsidiary One World Pharma S.A.S (3) Colombia Subsidiary Colombian Hope, S.A.S (4) Colombia Subsidiary Agrobase, S.A.S (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. The consolidated financial statements herein contain the operations of the wholly-owned subsidiaries listed above. The Company’s headquarters are located in Las Vegas, Nevada and substantially all of its production efforts are within Popayán, Colombia.
Reclassifications	Reclassifications Certain reclassifications have been made to the prior years’ financial statements to conform to current year presentation. These reclassifications had no effect on previously reported results of operations or retained earnings.
Foreign Currency Translation	Foreign Currency Translation The functional currency of the Company is Columbian Peso (COP). The Company has maintained its financial statements using the functional currency, and translated those financial statements to the US Dollar throughout this report. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency at rates of exchange prevailing at the balance sheet dates. Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Exchange gains or losses arising from foreign currency transactions are included in the determination of net income (loss) for the respective periods.
Comprehensive Income	Comprehensive Income The Company has adopted ASC 220, Reporting Comprehensive Income, which establishes standards for reporting and displaying comprehensive income, its components, and accumulated balances in a full-set of general-purpose financial statements. Accumulated other comprehensive income represents the accumulated balance of foreign currency translation adjustments.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Segment Reporting	Segment Reporting ASC Topic 280, “Segment Reporting,” requires use of the “management approach” model for segment reporting. The management approach model is based on the way a company’s management organizes segments within the company for making operating decisions and assessing performance. The Company operates as a single segment and will evaluate additional segment disclosure requirements as it expands its operations. ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company discloses the fair value of certain assets and liabilities in accordance with ASC 820, Fair Value Measurements and Disclosures (ASC 820). ASC 820 defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows: - Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets. - Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. - Level 3 inputs to valuation methodology are unobservable and significant to the fair measurement. The carrying value of cash, accounts receivable, accounts payables and accrued expenses are estimated by management to approximate fair value primarily due to the short-term nature of the instruments.
Cash in Excess of FDIC Insured Limits	Cash in Excess of FDIC Insured Limits The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. Accounts are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $ 250,000 not
Inventory	Inventory Inventories are stated at the lower of cost or net realizable value. Cost is determined on a standard cost basis that approximates the first-in, first-out (FIFO) method. Appropriate consideration is given to obsolescence, excessive levels, deterioration, and other factors in evaluating net realizable value. Our cannabis products consist of cannabis flower grown in-house, along with produced extracts.
Fixed Assets	Fixed Assets Fixed assets are stated at the lower of cost or estimated net recoverable amount. The cost of property, plant and equipment is depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based on the following life expectancy: Schedule of Estimated Useful Lives of Fixed Assets Buildings 15 Office equipment 5 Furniture and fixtures 7 Equipment and machinery 7 Leasehold improvements Term of lease Repairs and maintenance expenditures are charged to operations as incurred. Major improvements and replacements, which have extended the useful life of an asset, are capitalized and depreciated over the remaining estimated useful life of the asset. When assets are retired or sold, the cost and related accumulated depreciation and amortization are eliminated and any resulting gain or loss is reflected in operations.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. The Company’s sales to date have primarily consisted of the sale of seeds. These sales include multi-element arrangements whereby the Company collects 50% of the sale upon delivery of the sales, and the remaining 50% upon the completion of the harvest, whether the seeds result in a successful crop, or not. In addition, the Company has a right of first refusal to purchase products resulting from the harvest. At December 31, 2022, the Company had $ 11,808 6,655
Advertising Costs	Advertising Costs The Company expenses the cost of advertising and promotions as incurred. Advertising and promotions expense was $ 80,498 137,915 ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Basic and Diluted Loss Per Share	Basic and Diluted Loss Per Share The basic net loss per common share is computed by dividing the net loss by the weighted average number of common shares outstanding. Diluted net loss per common share is computed by dividing the net loss adjusted on an “as if converted” basis, by the weighted average number of common shares outstanding plus potential dilutive securities. For the years ended December 31, 2022 and 2021, potential dilutive securities had an anti-dilutive effect and were not included in the calculation of diluted net loss per common share.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for equity instruments issued to employees and non-employees in accordance with the provisions of ASC 718 Stock Compensation (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date of the fair value of the equity instrument issued is the earlier of the date on which the counterparty’s performance is complete or the date at which a commitment for performance by the counterparty to earn the equity instruments is reached because of sufficiently large disincentives for nonperformance.
Income Taxes	Income Taxes The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets to be more likely than not.
Uncertain Tax Positions	Uncertain Tax Positions In accordance with ASC 740, “Income Taxes” (“ASC 740”), the Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be capable of withstanding examination by the taxing authorities based on the technical merits of the position. These standards prescribe a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. These standards also provide guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. Various taxing authorities periodically audit the Company’s income tax returns. These audits include questions regarding the Company’s tax filing positions, including the timing and amount of deductions and the allocation of income to various tax jurisdictions. In evaluating the exposures connected with these various tax filing positions, including state and local taxes, the Company records allowances for probable exposures. A number of years may elapse before a particular matter, for which an allowance has been established, is audited and fully resolved. The Company has not yet undergone an examination by any taxing authorities. The assessment of the Company’s tax position relies on the judgment of management to estimate the exposures associated with the Company’s various filing positions.
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the FASB that are adopted by the Company as of the specified effective date. If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption. In October 2021, the FASB issued ASU 2021-08 , Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, ONE WORLD PRODUCTS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS In May 2021, the FASB issued ASU No. 2021-04, Earnings Per Share Debt – Modifications and Extinguishments Compensation and Derivatives and Hedging – Contracts in Entity’s Own Equity Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity Classified Written Call Options In March 2020, the FASB issued ASU 2020-04 establishing Topic 848, Reference Rate Reform In August 2020, the FASB issued ASU No. 2020-06, Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments. This guidance also eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments and requires the use of the if converted method. The new guidance is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2021, with early adoption permitted. The adoption of ASU 2020-06 has not had a material impact on the Company’s financial statements or related disclosures. There are no other recently issued accounting pronouncements that the Company has yet to adopt that are expected to have a material effect on its financial position, results of operations, or cash flows.

Nature of Business and Signif_3

Nature of Business and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of Common Control and Ownership Interest	The accompanying consolidated financial statements include the accounts of the following entities, all of which were under common control and ownership at December 31, 2022: Schedule of Common Control and Ownership Interest State of Name of Entity Incorporation Relationship One World Products, Inc (1) Nevada Parent OWP Ventures, Inc (2) Delaware Subsidiary One World Pharma S.A.S (3) Colombia Subsidiary Colombian Hope, S.A.S (4) Colombia Subsidiary Agrobase, S.A.S (5) Colombia Subsidiary (1) Holding company in the form of a corporation. (2) Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc. (3) Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá. (4) Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses. (5) Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.
Schedule of Estimated Useful Lives of Fixed Assets	Schedule of Estimated Useful Lives of Fixed Assets Buildings 15 Office equipment 5 Furniture and fixtures 7 Equipment and machinery 7 Leasehold improvements Term of lease

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Schedule of Agreement to Purchase Shares of Preferred Stock	Schedule of Agreement to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2022
Investments, All Other Investments [Abstract]
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis	The following schedule summarizes the valuation of financial instruments at fair value on a recurring basis in the balances sheet as of December 31, 2022 and 2021: Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2022 Level 1 Level 2 Level 3 Assets Cash $ 11,016 $ - $ - Right-of-use asset - - 425,969 Total assets 11,016 - 425,969 Liabilities Lease liabilities - 427,915 Convertible notes payable, net of $412,673 of debt discounts - 337,327 - Convertible notes payable - 750,000 - Notes payable - 845,524 - Notes payable, related parties - 299,500 - Total liabilities - (1,895,024 ) (427,915 ) Total assets and liabilities $ 11,016 $ (1,895,024 ) $ (1,946 ) Level 1 Level 2 Level 3 Fair Value Measurements at December 31, 2021 Level 1 Level 2 Level 3 Assets Cash $ 119,678 $ - $ - Total assets 119,678 - - Liabilities Convertible notes payable, net of $ 412,673 - 337,327 - Notes payable - 119,274 - Notes payable, related parties - 200,000 - Total liabilities - (656,601 ) - Total assets and liabilities $ 119,678 $ (656,601 ) $ -

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory	Schedule of Inventory December 31, December 31, 2022 2021 Raw materials $ 18,580 $ 31,233 Work in progress 1,464 81,182 Finished goods 80,858 108,246 Inventory gross 100,902 220,661 Less obsolescence (46,749 ) (22,066 ) Total inventory $ 54,153 $ 198,595

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Other Current Assets	Other current assets included the following as of December 31, 2022 and 2021, respectively: Schedule of Other Current Assets December 31, December 31, 2022 2021 Prepaid expenses $ 39,288 $ 29,366 Deferred cost of goods sold 6,655 19,470 Other receivables - 110,000 Total $ 45,943 $ 158,836

Security Deposits (Tables)

Security Deposits (Tables)	12 Months Ended
	Dec. 31, 2022
Security Deposits
Schedule of Security Deposits	Security deposits included the following as of December 31, 2022 and 2021, respectively: Schedule of Security Deposits December 31, December 31, 2022 2021 Utility deposits $ - $ 1,090 Refundable deposit on equipment purchase 50,000 50,000 Down payment on distillation equipment 1,399,413 1,155,000 Security deposits on leases held in Colombia 395 35,869 Security deposit on office lease - 14,029 Security deposits $ 1,449,808 $ 1,255,988

Fixed Assets (Tables)

Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Fixed Assets	Fixed assets consist of the following at December 31, 2022 and 2021, respectively: Schedule of Fixed Assets December 31, December 31, 2022 2021 Land $ 138,248 $ 138,248 Buildings 473,971 473,971 Office equipment 30,902 56,502 Furniture and fixtures 6,495 34,409 Equipment and machinery 423,547 383,829 Fixed assets, gross 1,073,163 1,086,959 Less: accumulated depreciation (84,627 ) (83,946 ) Total $ 988,536 $ 1,003,013

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses consisted of the following at December 31, 2022 and 2021, respectively: Schedule of Accrued Expenses December 31, December 31, 2022 2021 Accrued payroll $ 613,569 $ 261,044 Accrued withholding taxes and employee benefits 31,632 9,162 Accrued ICA fees and contributions 167,037 129,856 Accrued interest 136,220 57,700 Accrued expenses $ 948,458 $ 457,762

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2022
Leases
Schedule of Components of Lease Expense	The components of lease expense were as follows: Schedule of Components of Lease Expense 2022 2021 For the Year Ended December 31, 2022 2021 Operating lease cost: Amortization of right-of-use assets $ 114,907 $ 87,276 Interest on lease liabilities 83,702 3,035 Lease payments on short term leases 23,811 - Total operating lease cost $ 222,420 $ 90,311
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to leases was as follows: Schedule of Supplemental Balance Sheet Information Related to Leases December 31, December 31, 2022 2021 Operating lease: Operating lease assets $ 425,969 $ - Current portion of operating lease liabilities $ 86,235 - Noncurrent operating lease liabilities 341,680 - Total operating lease liability $ 427,915 $ - Weighted average remaining lease term: Operating leases 4.25 - Weighted average discount rate: Operating lease 6.75 % -
Schedule of Supplemental Cash Flow Related to Operating Leases	Supplemental cash flow and other information related to operating leases was as follows: Schedule of Supplemental Cash Flow Related to Operating Leases 2022 2021 For the Year Ended December 31, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows used for operating leases $ 96,253 $ 201,525 Early extinguishment of lease: Lease liability terminated $ 1,438,830 $ - Right-of use asset terminated (1,418,682 ) - Gain on early extinguishment of lease $ 20,148 $ - Leased assets obtained in exchange for lease liabilities: Total operating lease liabilities $ 1,962,998 $ -
Schedule of Operating Lease Liability Maturity	Our anticipated future lease commitments on a calendar year basis in US dollars, excluding common area maintenance fees, under non-cancelable operating leases are as follows: Schedule of Operating Lease Liability Maturity Minimum Year Ending Lease December 31, Commitments 2023 $ 112,508 2024 107,632 2025 99,186 2026 102,162 2027 78,336 Total future minimum lease liabilities $ 499,824

Convertible Note Payable (Table

Convertible Note Payable (Tables)	12 Months Ended
	Dec. 31, 2022
Schedule of Convertible Note Payable	Convertible note payable consists of the following at December 31, 2022 and 2021, respectively: Schedule of Convertible Note Payable December 31, December 31, 2022 2021 On September 27, 2022, $ 750,000 $ - On September 27, 2022, the Company completed the sale of a Convertible Promissory Note in the principal amount of $ 750,000 8 15 $ 750,000 $ - On September 24, 2021, the Company completed the sale of a (i) Promissory Note in the principal amount of $ 750,000 three 1,500,000 0.25 three 2,000,000 0.50 705,000 197 0.1053 0.1001 358,017 678,750 45,000 15,000 11,250 The Note matures on September 24, 2022 8 20 Pursuant to the Purchase Agreement, the Company paid a commitment fee to AJB Capital in the amount of $ 250,000 1,250,000 150,062 The obligations of the Company to AJB Capital under the Note and the Purchase Agreement are secured by a lien on the Company’s assets pursuant to a Security Agreement between the Company and AJB Capital. The note was repaid on September 27, 2022. $ - $ 750,000 Total convertible notes payable 750,000 750,000 Less: unamortized debt discounts - 412,673 Convertible note payable, net of discounts $ 750,000 $ 337,327
A J B Capital [Member]
Schedule of Convertible Debt Discounts	The Company recognized debt discounts for the years ended December 31, 2022 and 2021, as follows: Schedule of Convertible Debt Discounts December 31, December 31, 2022 2021 Fair value of 3,250,000 $ 106,894 $ 418,312 Fair value of warrants to purchase 3,500,000 255,026 358,017 Original issue discounts 32,055 53,700 Legal and brokerage fees 18,698 39,300 Total debt discounts 412,673 869,329 Amortization of debt discounts 412,673 456,656 Unamortized debt discounts $ - $ 412,673

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Payable
Schedule of Notes Payable	Notes payable consists of the following at December 31, 2022 and 2021, respectively: Schedule of Notes Payable December 31, December 31, 2022 2021 On September 15, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 55,488,000 12,243 70,000,000 15,445 4% 3,202 893 $ 14,552 $ - On June 17, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 230,400,000 55,821 240,000,000 58,147 4% 2,326 8,253 49,894 - On June 13, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 100,000 January 1, 2024 8% 100,000 - On May 31, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received proceeds of 314,640,000 76,231 360,000,000 87,220 2.1% 10,990 12,380 74,841 - On May 30, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 20,000,000 4,846 688 4,158 - On April 29, 2022, the Company, through its wholly-owned subsidiary, One World Pharma, SAS, received a non-interest bearing loan of 10,000,000 2,423 344 2,079 - On March 1, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 400,000 January 1, 2024 8% 400,000 - On February 15, 2022, the Company, through its wholly-owned subsidiary, OWP Ventures, Inc., received an advance of $ 200,000 January 1, 2024 8% 200,000 - On May 4, 2020, the Company, through its wholly-owned subsidiary OWP Ventures, Inc., borrowed $ 119,274 1.00% May 4, 2022 40% 121,372 119,274 2,098 February 11, 2022 - 119,274 Total notes payable 845,524 119,274 Less: current maturities 145,524 119,274 Notes payable, long-term portion $ 700,000 $ -

Notes Payable, Related Party (T

Notes Payable, Related Party (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Payable Related Party
Schedule of Notes Payable Related Party	Notes payable, related party, consists of the following at December 31, 2022 and 2021, respectively: Schedule of Notes Payable Related Party December 31, December 31, 2022 2021 On August 5, 2022, the Company received an advance of $ 50,000 6 $ 50,000 $ - On August 2, 2022, the Company received an advance of $ 4,500 6 4,500 - On July 7, 2022, the Company received an advance of $ 5,000 6 5,000 - On June 3, 2022, the Company received an advance of $ 10,000 6 10,000 - On May 5, 2022, the Company received an advance of $ 10,000 6 10,000 - On May 5, 2022, the Company received an advance of $ 20,000 6 20,000 - On December 29, 2021, the Company received an advance of $ 200,000 January 1, 2024 8 200,000 200,000 Total notes payable. related party 299,500 200,000 Less: current maturities 99,500 - Notes payable, related party, long-term portion $ 200,000 $ 200,000
Schedule of Interest Expenses	The Company recognized interest expense for the year ended December 31, 2022 and 2021, respectively, as follows: Schedule of Interest Expenses December 31, December 31, 2022 2021 Interest on convertible notes $ 59,023 $ 17,260 Interest on notes payable 85,653 18,945 Interest on notes payable, related parties 19,127 9,729 Amortization of debt discounts on convertible notes 50,753 42,247 Amortization of debt discounts on convertible notes, common stock 106,894 311,418 Amortization of debt discounts on convertible notes, warrants 255,026 102,991 Finance cost on equity line of credit, issuances of series B preferred stock 205,005 - Finance cost on equity line of credit, issuances of common stock 134,128 - Finance cost on equity line of credit 30,000 - Interest on accounts payable 11,249 8,541 Total interest expense $ 956,858 $ 511,131

Convertible Preferred Stock (Ta

Convertible Preferred Stock (Tables)	12 Months Ended
	Dec. 31, 2022
Convertible Preferred Stock
Schedule to Purchase Shares of Preferred Stock	Schedule to Purchase Shares of Preferred Stock Date Shares Purchase Price Initial Closing Date 16,666 $ 249,990 February 22, 2021 16,667 250,005 March 8, 2021 16,667 250,005 March 22, 2021 16,667 250,005 April 5, 2021 16,666 249,990 April 19, 2021 16,667 250,005 May 17, 2021 33,334 500,010 June 14, 2021 33,333 499,995 July 12, 2021 33,333 499,995 Total 200,000 $ 3,000,000

Common Stock Options (Tables)

Common Stock Options (Tables)	12 Months Ended
	Dec. 31, 2022
Common Stock Options
Schedule of Option Exercise Price Range	The following is a summary of information about the Stock Options outstanding at December 31, 2022. Schedule of Option Exercise Price Range Shares Underlying Shares Underlying Options Outstanding Options Exercisable Weighted Shares Average Weighted Shares Weighted Underlying Remaining Average Underlying Average Range of Options Contractual Exercise Options Exercise Exercise Prices Outstanding Life Price Exercisable Price $ 0.13 0.56 10,242,000 8.05 $ 0.15 9,113,528 $ 0.15
Schedule of Option Activity	The following is a summary of activity of outstanding stock options: Schedule of Option Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2020 1,275,000 $ 0.36 Options granted 9,592,000 0.14 Options exercised (125,000 ) (0.13 ) Balance, December 31, 2021 10,742,000 0.16 Options granted - - Options expired (500,000 ) (0.50 ) Balance, December 31, 2022 10,242,000 $ 0.15 Exercisable, December 31, 2022 9,113,528 $ 0.15

Common Stock Warrants (Tables)

Common Stock Warrants (Tables)	12 Months Ended
	Dec. 31, 2022
Common Stock Warrants
Schedule of Warrants to Purchase Common Stock Outstanding	The following is a summary of information about our warrants to purchase common stock outstanding at December 31, 2022. Schedule of Warrants to Purchase Common Stock Outstanding Shares Underlying Warrants Outstanding Shares Underlying Warrants Exercisable Range of Exercise Prices Shares Underlying Warrants Outstanding Weighted Average Remaining Contractual Life Weighted Average Exercise Price Shares Underlying Warrants Exercisable Weighted Average Exercise Price $ 0.25 0.50 11,511,650 2.43 $ 0.25 0.50 11,511,650 $ 0.25 0.50
Schedule of Fair value Assumption of Warrants	The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan: Schedule of Fair value Assumption of Warrants December 31, December 31, 2022 2021 Average risk-free interest rates 3.79 % 0.47 % Average expected life (in years) 5.00 3.00 Volatility 157 % 197 %
Schedule of Warrants Activity	The following is a summary of activity of outstanding common stock warrants: Schedule of Warrants Activity Weighted Average Number Exercise of Shares Prices Balance, December 31, 2020 7,511,650 $ 0.25 Warrants granted 3,500,000 0.39 Balance, December 31, 2021 11,011,650 0.30 Warrants granted 500,000 0.25 Balance, December 31, 2022 11,511,650 $ 0.29 Exercisable, December 31, 2022 11,511,650 $ 0.29

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate	Schedule of Effective Income Tax Rate 2022 2021 December 31, 2022 2021 Federal statutory income tax rate 21 % 21 % State income taxes - % - Change in valuation allowance (21 %) (21 %) Net effective income tax rate - -
Schedule of Deferred Tax Asset	The components of the Company’s deferred tax asset are as follows: Schedule of Deferred Tax Asset 2022 2021 December 31, 2022 2021 Deferred tax assets: Net operating loss carry forwards $ 1,950,000 $ 1,535,000 Net deferred tax assets before valuation allowance $ 1,950,000 $ 1,535,000 Less: Valuation allowance (1,950,000 ) (1,535,000 ) Net deferred tax assets $ - $ -

Schedule of Common Control and

Schedule of Common Control and Ownership Interest (Details)	12 Months Ended
	Dec. 31, 2022
Name of entity	ONE WORLD PRODUCTS, INC.
State of incorporation	NV
One World Products, Inc. [Member]
Name of entity	One World Products, Inc	[1]
State of incorporation	NV
Relationship	Parent
OWP Ventures, Inc. [Member]
Name of entity	OWP Ventures, Inc	[2]
State of incorporation	DE
Relationship	Subsidiary
One World Pharma S.A.S. [Member]
Name of entity	One World Pharma S.A.S	[3]
State of incorporation	F8
Relationship	Subsidiary
Colombian Hope, S.A.S. [Member]
Name of entity	Colombian Hope, S.A.S	[4]
State of incorporation	F8
Relationship	Subsidiary
Agrobase, S.A.S. [Member]
Name of entity	Agrobase, S.A.S	[5]
State of incorporation	F8
Relationship	Subsidiary
[1]Holding company in the form of a corporation.[2]Holding company in the form of a corporation and wholly-owned subsidiary of One World Products, Inc.[3]Wholly-owned subsidiary of OWP Ventures, Inc. since May 30, 2018, located in Colombia and legally constituted as a simplified stock company registered in the Chamber of Commerce of Bogotá on July 18, 2017. Its headquarters are located in Bogotá.[4]Wholly-owned subsidiary of OWP Ventures, Inc., acquired on November 19, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.[5]Wholly-owned subsidiary of OWP Ventures, Inc., formed on September 12, 2019, located in Colombia and legally constituted as a simplified stock company. This company has yet to incur any substantive income or expenses.

Schedule of Estimated Useful Li

Schedule of Estimated Useful Lives of Fixed Assets (Details)	12 Months Ended
	Dec. 31, 2022
Building [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives, description	Term of lease

Nature of Business and Signif_4

Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended	12 Months Ended
	Feb. 21, 2019	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Oct. 01, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance convertible note			$ 750,000
Lease term					5 years
FDIC insured amount			250,000
Cash uninsured amount
Deferred revenue			11,808	30,164
Deferred revenue cost of goods sold			6,655	19,470
Advertising and promotions expense			$ 80,498	$ 137,915
Merger Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Options to purchase common stock	825,000
Common stock exercise price	$ 0.50
Merger Agreement [Member] | OWP Ventures, Inc. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of stock issued	39,475,398
Options to purchase common stock	825,000
Common stock exercise price	$ 0.50
Proceeds from issuance convertible note	$ 300,000
Conversion price	$ 0.424
Number of shares cancelled	875,000
Payment for machinery		$ 1,400,000

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital	$ 2,853,968
Accumulated deficit	$ 22,976,365	$ 19,916,888

Schedule of Agreement to Purcha

Schedule of Agreement to Purchase Shares of Preferred Stock (Details) - USD ($)														5 Months Ended	12 Months Ended
	Oct. 12, 2022	Oct. 03, 2022	Sep. 12, 2022	Jul. 12, 2021	Jun. 14, 2021	May 17, 2021	Apr. 19, 2021	Apr. 05, 2021	Mar. 22, 2021	Mar. 08, 2021	Feb. 22, 2021	Feb. 07, 2021	Feb. 07, 2021	Jul. 12, 2021	Dec. 31, 2021
Purchase price	$ 15,000
Series B Preferred Stock [Member]
Shares	10,000	3,333,300	10,000
Purchase price	$ 150,000	$ 499,995	$ 150,000
ISIAH International, LLC [Member] | Share Purchase Agreement [Member] | Series B Preferred Stock [Member]
Shares				33,333	33,333	33,334	16,667	16,666	16,667	16,667	16,667	200,000	16,666	200,000
Purchase price				$ 499,995	$ 499,995	$ 500,010	$ 250,005	$ 249,990	$ 250,005	$ 250,005	$ 250,005	$ 3,000,000	$ 249,990	$ 3,000,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)

1 Months Ended

12 Months Ended

Oct. 12, 2022

Oct. 03, 2022

Sep. 12, 2022

Oct. 18, 2021

Sep. 15, 2021

Mar. 29, 2021

Feb. 07, 2021

Jan. 02, 2021

May 31, 2021

Dec. 31, 2022

Dec. 31, 2021

Jan. 28, 2022

Jul. 26, 2021

Jan. 01, 2021

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Purchase price per share

$ 0.50

$ 0.13

Issuance of common stock

$ 15,000

Preferred stock, par value

$ 0.001

$ 0.001

Number of options awarded during period, shares

134,128

Share-based compensation

$ 339,133

$ 133,755

Series B Preferred Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued, shares

10,000

3,333,300

10,000

Issuance of common stock

$ 150,000

$ 499,995

$ 150,000

Preferred stock, par value

$ 15

ISIAH International, LLC [Member] | Share Purchase Agreement [Member] | Series B Preferred Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued, shares

200,000

Conversion of stock, shares issuable

20,000,000

Purchase price per share

$ 15

Issuance of common stock

$ 3,000,000

Preferred stock, par value

$ 15

Conversion price per share

$ 0.15

Number of share purchase

200,000

Dr.Kenneth Perego II [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Expense reimbursements owed to related party

$ 65,382

Repayment of related party debt

$ 27,201

Debt principal amount

26,000

Interest payable

$ 1,201

Mr Timothy Woods [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Expense reimbursements owed to related party

2,505

Isiah Thomas [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Repayment of related party debt

$ 52,918

$ 130,610

Debt principal amount

50,000

125,000

Interest payable

$ 2,918

$ 5,610

Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options awarded during period, shares

5,500,000

Options exercise price, per share

$ 0.13

$ 0.13

Options exercisable period

10 years

Stock option, volatility rate

192%

Stock option, call option, price per share

$ 0.1174

Stock option, call option value

$ 645,624

Share-based compensation

117,388

410,853

Unamortized expenses

$ 117,383

Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Eleven Quarters [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options vested during period, shares

250,000

Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options vested during period, shares

2,750,000

Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options vested during period, shares

2,750,000

Isiah L Thomas III [Member] | Series B Preferred Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of shares issued, shares

3,334

Purchase price per share

$ 15

Proceeds from preferred stock

$ 50,010

Dr Ken Perego [Member] | 2019 Stock Incentive Plan [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Number of options awarded during period, shares

350,000

Options exercise price, per share

$ 0.13

Options exercisable period

10 years

Stock option, volatility rate

192%

Stock option, call option, price per share

$ 0.1170

Stock option, call option value

$ 40,943

Share-based compensation

$ 40,943

Schedule of Valuation of Financ

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Assets
Right-of-use asset	$ 425,969
Liabilities
Lease liabilities	427,915
Fair Value, Inputs, Level 1 [Member]
Assets
Cash	11,016	119,678
Right-of-use asset
Total assets	11,016	119,678
Liabilities
Convertible notes payable, net of $412,673 of debt discounts
Convertible notes payable
Notes payable
Notes payable, related parties
Total liabilities
Total assets and liabilities	11,016	119,678
Fair Value, Inputs, Level 2 [Member]
Assets
Cash
Right-of-use asset
Total assets
Liabilities
Lease liabilities
Convertible notes payable, net of $412,673 of debt discounts	337,327	337,327
Convertible notes payable	750,000
Notes payable	845,524	119,274
Notes payable, related parties	299,500	200,000
Total liabilities	(1,895,024)	(656,601)
Total assets and liabilities	(1,895,024)	(656,601)
Fair Value, Inputs, Level 3 [Member]
Assets
Cash
Right-of-use asset	425,969
Total assets	425,969
Liabilities
Lease liabilities	427,915
Convertible notes payable, net of $412,673 of debt discounts
Convertible notes payable
Notes payable
Notes payable, related parties
Total liabilities	(427,915)
Total assets and liabilities	$ (1,946)

Schedule of Valuation of Fina_2

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) (Parenthetical) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Investments, All Other Investments [Abstract]
Convertible notes payable, debt discounts	$ 0	$ 412,673

Major Customers and Accounts _2

Major Customers and Accounts Receivable (Details Narrative) - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue Benchmark [Member] | No Customers [Member]
Product Information [Line Items]
Accounts receivable	10%
Revenue Benchmark [Member] | Four Customers [Member]
Product Information [Line Items]
Accounts receivable		60%
Accounts Receivable [Member] | One Customers [Member]
Product Information [Line Items]
Accounts receivable	67%	75%

Schedule of Inventory (Details)

Schedule of Inventory (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 18,580	$ 31,233
Work in progress	1,464	81,182
Finished goods	80,858	108,246
Inventory gross	100,902	220,661
Less obsolescence	(46,749)	(22,066)
Total inventory	$ 54,153	$ 198,595

Schedule of Other Current Asset

Schedule of Other Current Assets (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 39,288	$ 29,366
Deferred cost of goods sold	6,655	19,470
Other receivables		110,000
Total	$ 45,943	$ 158,836

Other Assets (Details Narrative

Other Assets (Details Narrative) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Other assets	$ 179,927	$ 147,194

Schedule of Security Deposits (

Schedule of Security Deposits (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	$ 1,449,808	$ 1,255,988
Utilities Deposits [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits		1,090
Refundable Deposit On Equipment Purchase [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	50,000	50,000
Down Paymenton Distillation Equipment [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	1,399,413	1,155,000
Security Deposits On Leases Held In Colombia [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits	395	35,869
Security Deposit On Office Lease [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Security deposits		$ 14,029

Schedule of Fixed Assets (Detai

Schedule of Fixed Assets (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 1,073,163	$ 1,086,959
Less: accumulated depreciation	(84,627)	(83,946)
Total	988,536	1,003,013
Land [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	138,248	138,248
Building [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	473,971	473,971
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	30,902	56,502
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	6,495	34,409
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed assets, gross	$ 423,547	$ 383,829

Fixed Assets (Details Narrative

Fixed Assets (Details Narrative) - USD ($)				12 Months Ended
	Nov. 30, 2021	Jul. 27, 2021	Jul. 01, 2021	Dec. 31, 2022	Dec. 31, 2021	Aug. 15, 2022
Impairment Effects on Earnings Per Share [Line Items]
Office furniture and equipment				$ 988,536	$ 1,003,013
Proceeds from disposal of fixed assets	$ 0	$ 5,125	$ 0	6,350	5,125
Loss on disposal of fixed assets	$ 53,925	$ 2,064	$ 15,498	9,041	71,487
Depreciation and amortization expense				$ 42,287	$ 40,321
Office Furniture and Equipment [Member]
Impairment Effects on Earnings Per Share [Line Items]
Office furniture and equipment						$ 15,391

Schedule of Accrued Expenses (D

Schedule of Accrued Expenses (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued payroll	$ 613,569	$ 261,044
Accrued withholding taxes and employee benefits	31,632	9,162
Accrued ICA fees and contributions	167,037	129,856
Accrued interest	136,220	57,700
Accrued expenses	$ 948,458	$ 457,762

Deferred Revenues (Details Narr

Deferred Revenues (Details Narrative) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Deferred Revenues
Contract with customer, liability, current	$ 11,808	$ 30,164
Contract with customer, asset, after allowance for credit loss, current	6,655	19,470
Deferred revenue gross	$ 5,153	$ 10,964

Schedule of Components of Lease

Schedule of Components of Lease Expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating lease cost:
Amortization of right-of-use assets	$ 114,907	$ 87,276
Interest on lease liabilities	83,702	3,035
Lease payments on short term leases	23,811
Total operating lease cost	$ 222,420	$ 90,311

Schedule of Supplemental Balanc

Schedule of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Leases
Operating lease assets	$ 425,969
Current portion of operating lease liabilities	86,235
Noncurrent operating lease liabilities	341,680
Total operating lease liabilities	$ 427,915
Weighted average remaining lease term	4 years 3 months
Weighted average discount rate: operating leases	6.75%

Schedule of Supplemental Cash F

Schedule of Supplemental Cash Flow Related to Operating Leases (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Leases
Operating cash flows used for operating leases	$ 96,253	$ 201,525
Early extinguishment of lease:
Lease liability terminated	1,438,830
Right-of use asset terminated	(1,418,682)
Gain on early extinguishment of lease	20,148
Total operating lease liabilities	$ 1,962,998

Schedule of Operating Lease Lia

Schedule of Operating Lease Liability Maturity (Details)	Dec. 31, 2022 USD ($)
Leases
2023	$ 112,508
2024	107,632
2025	99,186
2026	102,162
2027	78,336
Total future minimum lease liabilities	$ 499,824

Leases (Details Narrative)

Leases (Details Narrative)									12 Months Ended
	Oct. 01, 2022 USD ($)	Oct. 01, 2022 COP ($)	Jun. 01, 2022 USD ($)	Jun. 01, 2022 COP ($)	Jan. 02, 2022 USD ($) ft²	Jan. 02, 2022 COP ($) ft²	Sep. 01, 2021 USD ($)	Sep. 01, 2021 COP ($)	Dec. 31, 2022 USD ($)
Leases
Square foot leased | ft²					12,400	12,400
Monthly lease payment	$ 6,300		$ 507	$ 1,900,000	$ 15,290	$ 57,339,000	$ 1,013	$ 3,800,000
Lease termination fees									$ 7,700
Gain on extinguishment									$ 20,148
VAT and administration fees		$ 29,000,000
Annual escalation of lease payment, percentage	2%	2%	8%	8%			3%	3%

Schedule of Convertible Note Pa

Schedule of Convertible Note Payable (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Notes payable, net of discounts	$ 145,524	$ 119,274
Convertible Debt [Member]
Short-Term Debt [Line Items]
Total convertible notes payable	750,000	750,000
Debt instrument, unamortized discount		412,673
Notes payable, net of discounts	750,000	337,327
Convertible Debt [Member] | Promissory Note [Member]
Short-Term Debt [Line Items]
Total convertible notes payable	750,000
Convertible Debt [Member] | Promissory Note One [Member]
Short-Term Debt [Line Items]
Total convertible notes payable		$ 750,000

Schedule of Convertible Note _2

Schedule of Convertible Note Payable (Details) (Parenthetical)			12 Months Ended
	Sep. 24, 2021 USD ($) Integer $ / shares shares	Sep. 17, 2021 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares	Sep. 27, 2022 USD ($) $ / shares
Short-Term Debt [Line Items]
Warrants exercise price | $ / shares			$ 0.29	$ 0.10
Warrants purchase | shares			11,511,650
Debt discount			$ 412,673	$ 456,656
Number of stock issued for commitment fee, shares			134,128	133,755
AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt discount			150,062	$ 268,250
Number of stock issued for commitment fee, shares		$ 2,000,000	$ 1,250,000
Promissory Note [Member] | John McCabe Investments LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, face value					$ 750,000
Debt interest rate					8%
Promissory Note [Member] | John McCabe Investments LLC [Member] | Series A Common Stock [Member]
Short-Term Debt [Line Items]
Warrants exercise price | $ / shares					$ 15
Promissory Note [Member] | AJB Capital Investments LLC [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 750,000
Debt interest rate	8%
Warrants exercise price | $ / shares	$ 0.25
Warrants term	3 years
Warrants purchase | shares	1,500,000
Debt discount	$ 150,062
Debt instrument maturity date	Sep. 24, 2022
Trading days | Integer	20
Number of stock issued for commitment fee, shares	$ 250,000
Number of stock issued for commitment fee | shares	1,250,000
Promissory Note [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 705,000
Warrants exercise price | $ / shares	$ 0.50
Warrants term	3 years
Warrants purchase | shares	2,000,000
Stock option, volatility rate	197%
Stock option, call option, price per share | $ / shares	$ 0.1053
Stock option, call option value	$ 358,017
Debt discount	678,750
Original issue discount	45,000
Legal fees	15,000
Brokerage fees	$ 11,250
Promissory Note [Member] | AJB Capital Investments LLC [Member] | Purchase Agreement [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Stock option, call option, price per share | $ / shares	$ 0.1001

Schedule of Convertible Debt Di

Schedule of Convertible Debt Discounts (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Debt Disclosure [Abstract]
Fair value of 3,250,000 commitment shares of common stock	$ 106,894	$ 418,312
Fair value of warrants to purchase 3,500,000 shares of common stock	255,026	358,017
Original issue discounts	32,055	53,700
Legal and brokerage fees	18,698	39,300
Total debt discounts	412,673	869,329
Amortization of debt discounts	412,673	456,656
Unamortized debt discounts		$ 412,673

Schedule of Convertible Debt _2

Schedule of Convertible Debt Discounts (Details) (Parenthetical)	Dec. 31, 2022 shares
Debt Disclosure [Abstract]
Fair value commitment	3,250,000
Fair value warrants purchase shares	3,500,000

Convertible Note Payable (Detai

Convertible Note Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Amortization of debt discount	$ 412,673	$ 869,329
Finance expense	$ 412,673	456,656
Common stock percentage	4.99%
Interest expense	$ 59,023	17,260
Debt discounts premium	412,673	456,656
Convertible Debt [Member]
Short-Term Debt [Line Items]
Interest expense	$ 59,023	$ 36,243

Schedule of Notes Payable (Deta

Schedule of Notes Payable (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Total notes payable	$ 845,524	$ 119,274
Less: current maturities	145,524	119,274
Notes payable, long-term portion	700,000
Unsecured Promissory Note One [Member]
Short-Term Debt [Line Items]
Total notes payable	14,552
Unsecured Promissory Note Two [Member]
Short-Term Debt [Line Items]
Total notes payable	49,894
Unsecured Promissory Note Three [Member]
Short-Term Debt [Line Items]
Total notes payable	100,000
Unsecured Promissory Note Four [Member]
Short-Term Debt [Line Items]
Total notes payable	74,841
Unsecured Promissory Note Five [Member]
Short-Term Debt [Line Items]
Total notes payable	4,158
Unsecured Promissory Note Six [Member]
Short-Term Debt [Line Items]
Total notes payable	2,079
Unsecured Promissory Note Seven [Member]
Short-Term Debt [Line Items]
Total notes payable	400,000
Unsecured Promissory Note Eight [Member]
Short-Term Debt [Line Items]
Total notes payable	200,000
Unsecured Promissory Note Nine [Member]
Short-Term Debt [Line Items]
Total notes payable		$ 119,274

Schedule of Notes Payable (De_2

Schedule of Notes Payable (Details) (Parenthetical)

12 Months Ended

Sep. 15, 2022 USD ($)

Sep. 15, 2022 COP ($)

Jun. 17, 2022 USD ($)

Jun. 17, 2022 COP ($)

Jun. 13, 2022 USD ($)

May 31, 2022 USD ($)

May 31, 2022 COP ($)

May 30, 2022 USD ($)

Apr. 29, 2022 USD ($)

Mar. 01, 2022 USD ($)

Feb. 15, 2022 USD ($)

May 04, 2020 USD ($)

Dec. 31, 2022 USD ($)

Dec. 31, 2021 USD ($)

Sep. 15, 2022 COP ($)

Jun. 17, 2022 COP ($)

May 31, 2022 COP ($)

May 30, 2022 COP ($)

Apr. 29, 2022 COP ($)

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 99,500

Unsecured Promissory Note One [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 12,243

$ 55,488,000

Face value

$ 15,445

$ 70,000,000

Debt interest rate

4%

4%

Debt discount

$ 3,202

Foreign currency translation adjustment

$ 893

Unsecured Promissory Note Two [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 55,821

$ 230,400,000

Face value

$ 58,147

$ 240,000,000

Debt interest rate

4%

4%

Debt discount

$ 2,326

Foreign currency translation adjustment

$ 8,253

Unsecured Promissory Note Three [Member] | OWP Ventures, Inc. [Member]

Short-Term Debt [Line Items]

Face value

$ 100,000

Debt interest rate

8%

Debt instrument, maturity date

Jan. 01, 2024

Unsecured Promissory Note Four [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Proceeds from subsidiary

$ 76,231

$ 314,640,000

Face value

$ 87,220

$ 360,000,000

Debt interest rate

2.10%

2.10%

Debt discount

$ 10,990

Foreign currency translation adjustment

$ 12,380

Unsecured Promissory Note Five [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 4,846

$ 20,000,000

Foreign currency translation adjustment

$ 688

Unsecured Promissory Note Six [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 2,423

$ 10,000,000

Foreign currency translation adjustment

$ 344

Unsecured Promissory Note Seven [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 400,000

Debt interest rate

8%

Debt instrument, maturity date

Jan. 01, 2024

Unsecured Promissory Note Eight [Member] | One World Pharma S.A.S. [Member]

Short-Term Debt [Line Items]

Face value

$ 200,000

Debt interest rate

8%

Debt instrument, maturity date

Jan. 01, 2024

Unsecured Promissory Note Nine [Member] | OWP Ventures, Inc. [Member]

Short-Term Debt [Line Items]

Debt instrument, maturity date

May 04, 2022

Loan forgiveness, percentage

40%

Debt

$ 121,372

Principal payment

119,274

Interest rate

$ 2,098

Debt instrument, maturity date

Feb. 11, 2022

Unsecured Promissory Note Nine [Member] | OWP Ventures, Inc. [Member] | Lenders [Member]

Short-Term Debt [Line Items]

Debt interest rate

1%

Advance from affiliates

$ 119,274

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Notes Payable
Interest expense	$ 85,653	$ 18,945

Schedule of Notes Payable Relat

Schedule of Notes Payable Related Party (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Short-Term Debt [Line Items]
Less: current maturities	$ 99,500
Notes payable, related party, long-term portion	200,000	200,000
Unsecured Promissory Note One [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	50,000
Unsecured Promissory Note Two [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	4,500
Unsecured Promissory Note Three [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	5,000
Unsecured Promissory Note Four [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	10,000
Unsecured Promissory Note Five [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	10,000
Unsecured Promissory Note Six [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	20,000
Unsecured Promissory Note Seven [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	200,000	200,000
Unsecured Promissory Notes [Member]
Short-Term Debt [Line Items]
Total notes payable. related party	$ 299,500	$ 200,000

Schedule of Notes Payable Rel_2

Schedule of Notes Payable Related Party (Details) (Parenthetical) - USD ($)	Dec. 29, 2021	Aug. 05, 2022	Aug. 02, 2022	Jul. 07, 2022	Jun. 03, 2022	May 05, 2022	Mar. 29, 2021
Dr.Kenneth Perego II [Member]
Short-Term Debt [Line Items]
Debt instrument, face value							$ 26,000
Unsecured Promissory Note [Member] | Dr.Kenneth Perego II [Member]
Short-Term Debt [Line Items]
Debt instrument, face value	$ 200,000	$ 50,000		$ 5,000		$ 20,000
Debt interest rate, percentage	8%	6%		6%		6%
Debt Instrument, Maturity Date	Jan. 01, 2024
Unsecured Promissory Note [Member] | Isiah Thomas III [Member]
Short-Term Debt [Line Items]
Debt instrument, face value			$ 4,500		$ 10,000	$ 10,000
Debt interest rate, percentage			6%		6%	6%

Schedule of Interest Expenses (

Schedule of Interest Expenses (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Notes Payable Related Party
Interest on convertible notes	$ 59,023	$ 17,260
Interest on notes payable	85,653	18,945
Interest on notes payable, related parties	19,127	9,729
Amortization of debt discounts on convertible notes	50,753	42,247
Amortization of debt discounts on convertible notes, common stock	106,894	311,418
Amortization of debt discounts on convertible notes, warrants	255,026	102,991
Finance cost on equity line of credit, issuances of series B preferred stock	205,005
Finance cost on equity line of credit, issuances of common stock	134,128
Finance cost on equity line of credit	30,000
Interest on accounts payable	11,249	8,541
Total interest expense	$ 956,858	$ 511,131

Notes Payable, Related Party (D

Notes Payable, Related Party (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Notes Payable Related Party
Interest expense	$ 19,127	$ 9,729

Schedule to Purchase Shares of

Schedule to Purchase Shares of Preferred Stock (Details) - USD ($)														5 Months Ended	12 Months Ended
	Oct. 12, 2022	Oct. 03, 2022	Sep. 12, 2022	Jul. 12, 2021	Jun. 14, 2021	May 17, 2021	Apr. 19, 2021	Apr. 05, 2021	Mar. 22, 2021	Mar. 08, 2021	Feb. 22, 2021	Feb. 07, 2021	Feb. 07, 2021	Jul. 12, 2021	Dec. 31, 2021
Purchase price	$ 15,000
Series B Preferred Stock [Member]
Shares	10,000	3,333,300	10,000
Purchase price	$ 150,000	$ 499,995	$ 150,000
ISIAH International, LLC [Member] | Share Purchase Agreement [Member] | Series B Preferred Stock [Member]
Shares				33,333	33,333	33,334	16,667	16,666	16,667	16,667	16,667	200,000	16,666	200,000
Purchase price				$ 499,995	$ 499,995	$ 500,010	$ 250,005	$ 249,990	$ 250,005	$ 250,005	$ 250,005	$ 3,000,000	$ 249,990	$ 3,000,000

Convertible Preferred Stock (De

Convertible Preferred Stock (Details Narrative) - USD ($)																						1 Months Ended		5 Months Ended	12 Months Ended
	Dec. 21, 2022	Dec. 21, 2022	Oct. 12, 2022	Oct. 03, 2022	Sep. 12, 2022	Sep. 01, 2022	Nov. 15, 2021	Jul. 12, 2021	Jun. 14, 2021	May 17, 2021	Apr. 19, 2021	Apr. 06, 2021	Apr. 05, 2021	Mar. 24, 2021	Mar. 22, 2021	Mar. 08, 2021	Feb. 22, 2021	Feb. 07, 2021	Feb. 07, 2021	Jan. 26, 2021	Jan. 12, 2021	Dec. 31, 2022	Apr. 22, 2021	Jul. 12, 2021	Dec. 31, 2022	Dec. 31, 2021	Jan. 28, 2022	Jul. 26, 2021
Preferred stock, shares authorized																						9,200,000			9,200,000	9,200,000
Preferred stock, par value																						$ 0.001			$ 0.001	$ 0.001
Number of warrants to purchase common stock																						3,500,000			3,500,000
Exercise price of warrants																						$ 0.29			$ 0.29	$ 0.10
Preferred stock dividend recognized																									$ 38,923	$ 61,684
Issuance of common stock			$ 15,000
Purchase price per share																											$ 0.50	$ 0.13
ELOC Purchase Agreement [Member] | Tysadco Partners, LLC [Member]
Issuance of common stock						$ 10,000,000
Commitment fees shares																						13,667
Series A Convertible Preferred Stock [Member]
Preferred stock, shares authorized																						10,000,000			10,000,000
Preferred stock, par value																						$ 0.001			$ 0.001	$ 0.001
Preferred stock shares designated																						500,000			500,000
Conversion of preferred stock into common stock, description																									The Series A Preferred Stock accrues dividends at the rate of 6% per annum, payable in cash as and when declared by the Board or upon a liquidation.
Dividend rate percentage																									6%
Series A convertible preferred stock, outstanding																						70,233			70,233	65,233
Purchase price per share																						$ 0.60			$ 0.60	$ 0.60
Series B Convertible Preferred Stock [Member]
Preferred stock, par value																						$ 0.001			$ 0.001	$ 0.001
Preferred stock shares designated																						300,000			300,000
Series A convertible preferred stock, outstanding																						272,168			272,168	238,501
Series A Preferred Stock [Member]
Preferred stock, shares authorized																						10,000,000			10,000,000
Preferred stock, par value																						$ 0.001			$ 0.001
Preferred stock shares designated																						500,000			500,000
Dividend rate percentage																									6%
Preferred stock, par value																						$ 10			$ 10
Number of stock sold, shares		5,000
Conversion of stock, shares converted							30,000					30,000		10,000						5,000	10,000
Dividends, Preferred Stock, Cash																									$ 137,843
Series A Preferred Stock [Member] | Preferred Stock Sales [Member]
Fair value of sale of stock	$ 50,000
Number of stock sold, shares	5,000
Warrant term	5 years	5 years
Number of warrants to purchase common stock	500,000	500,000
Exercise price of warrants	$ 0.25	$ 0.25
Series B Preferred Stock [Member]
Preferred stock shares designated																						300,000			300,000
Preferred stock, par value																						$ 15			$ 15
Number of shares issued, shares			10,000	3,333,300	10,000
Issuance of common stock			$ 150,000	$ 499,995	$ 150,000
Series B Preferred Stock [Member] | Seven Accredited Investors [Member]
Number of shares issued, shares																							35,167
Issuance of common stock																							$ 527,520
Purchase price per share																							$ 15
Series B Preferred Stock [Member] | Isiah L Thomas III [Member]
Number of shares issued, shares				33,333																			3,334
Issuance of common stock																							$ 50,010
Purchase price per share																							$ 15
Series B Preferred Stock [Member] | Share Purchase Agreement [Member] | Tysadco Partners, LLC [Member]
Preferred stock, par value						$ 15
Number of shares issued, shares						20,000
Issuance of common stock						$ 300,000
Series B Preferred Stock [Member] | Share Purchase Agreement [Member] | ISIAH International, LLC [Member]
Preferred stock, par value																		$ 15	$ 15
Number of shares issued, shares								33,333	33,333	33,334	16,667		16,666		16,667	16,667	16,667	200,000	16,666					200,000
Issuance of common stock								$ 499,995	$ 499,995	$ 500,010	$ 250,005		$ 249,990		$ 250,005	$ 250,005	$ 250,005	$ 3,000,000	$ 249,990					$ 3,000,000
Conversion of stock, shares issuable																		20,000,000
Purchase price per share																		$ 15	$ 15
Conversion of stock conversion price per share																		$ 0.15	$ 0.15
Share purchase																		200,000
Series B Preferred Stock [Member] | ELOC Purchase Agreement [Member] | Tysadco Partners, LLC [Member]
Fair value of sale of stock																						$ 205,005
Common Stock [Member]
Conversion of stock, shares issued							3,000,000					3,000,000		1,000,000						500,000	1,000,000

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)						1 Months Ended	12 Months Ended
	Oct. 12, 2022	Oct. 03, 2022	Sep. 15, 2022	Sep. 12, 2022	Sep. 01, 2022	Apr. 22, 2021	Dec. 31, 2021
Common stock sold for cash	$ 15,000
Series B Preferred Stock [Member]
Common stock sold for cash	$ 150,000	$ 499,995		$ 150,000
Common stock sold for cash, shares	10,000	3,333,300		10,000
Isiah L Thomas III [Member] | Series B Preferred Stock [Member]
Common stock sold for cash						$ 50,010
Common stock sold for cash, shares		33,333				3,334
Common Stock [Member]
Common stock sold for cash							$ 750
Common stock sold for cash, shares			1,341,276				750,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member]
Common stock sold for cash					$ 10,000,000
Tysadco Partners, LLC [Member] | ELOC Purchase Agreement [Member] | Common Stock [Member]
Common stock, conversion basis					The purchase price of the shares of common stock to be purchased under the Purchase Agreement will be equal to 88% of the lowest daily “VWAP” during the period of 10 trading days beginning five trading days preceding the applicable Request. Each purchase under the Purchase Agreement will be in a minimum amount of $25,000 and a maximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trading value of the common stock over the seven trading days preceding the delivery of the applicable Request Notice.

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative) - USD ($)															12 Months Ended
	Dec. 21, 2022	Oct. 12, 2022	Oct. 03, 2022	Sep. 15, 2022	Sep. 12, 2022	Mar. 29, 2022	Dec. 31, 2021	Dec. 01, 2021	Sep. 17, 2021	Jul. 26, 2021	Jun. 01, 2021	May 25, 2021	May 23, 2021	May 12, 2021	Dec. 31, 2022	Dec. 31, 2021	Jan. 28, 2022	Oct. 15, 2021
Class of Stock [Line Items]
Preferred Stock, Shares Authorized							9,200,000								9,200,000	9,200,000
Common stock, shares authorized							300,000,000								300,000,000	300,000,000
Common stock, par value							$ 0.001								$ 0.001	$ 0.001
Common stock, shares outstanding							65,599,565								67,202,907	65,599,565
Common stock, shares outstanding							65,599,565								67,202,907	65,599,565
Number of stock issued for services, value															$ 134,128	$ 133,755
Amortization of debt discounts															$ 412,673	456,656
Fair value of shares															134,128
Exercise of cashless options, shares										60,000
Options outstanding										125,000							500,000
Purchase price per share										$ 0.13							$ 0.50
Two Individuals [Member]
Class of Stock [Line Items]
Number of stock issued for services, value								$ 21,725			$ 18,758	$ 8,500		$ 29,538
Number of stock issued for services								262,066			112,528		50,000	118,150
Purchase Agreement [Member] | AJB Capital Investments LLC [Member]
Class of Stock [Line Items]
Debt instrument, fee amount									$ 200,000						$ 250,000
Number of stock issued for services, value									$ 2,000,000						1,250,000
Amortization of debt discounts															150,062	268,250
Finance expense															106,894	43,168
Purchase Agreement [Member] | Second ABJ Note [Member]
Class of Stock [Line Items]
Finance expense																268,250
Common Stock [Member]
Class of Stock [Line Items]
Number of stock issued for services, value															$ 1,603	$ 955
Common stock sold for cash, shares				1,341,276												750,000
Exercise of cashless options, shares																60,000
Number of stock issued for services															1,603,342	954,260
Common Stock [Member] | Vahe Gabriel [Member]
Class of Stock [Line Items]
Number of stock issued for services, value							$ 55,234
Number of stock issued for services							673,582
Common Stock [Member] | Subscription Payable [Member]
Class of Stock [Line Items]
Number of stock sold, shares						262,066
Sale of stock price per share																		$ 1
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized															10,000,000
Temporary Equity, Par or Stated Value Per Share															$ 0.001
Preferred stock shares designated															500,000
Number of stock sold, shares	5,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock shares designated															300,000
Common stock sold for cash, shares		10,000	3,333,300		10,000

Schedule of Option Exercise Pri

Schedule of Option Exercise Price Range (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Common Stock Options
Shares Underlying Options Outstanding, Exercise Price Range, Lower Range Limit	$ 0.13
Shares Underlying Options Outstanding, Exercise Price Range, Upper Range Limit	$ 0.56
Shares Underlying Options Outstanding, shares | shares	10,242,000
Shares Underlying Options Outstanding, Weighted Average Remaining Life (Years)	8 years 18 days
Shares Underlying Options Outstanding, Weighted Average Exercise Price	$ 0.15
Shares Underlying Options Exercisable, Number of shares, shares | shares	9,113,528
Shares Underlying Options Exercisable, Weighted Average Exercise Price	$ 0.15

Schedule of Option Activity (De

Schedule of Option Activity (Details) - $ / shares		12 Months Ended
	Jul. 26, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Options granted		134,128
Number of Shares, Options exercised	(60,000)
Number of Shares, Ending	125,000
Stock Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares, Beginning		10,742,000	1,275,000
Weighted Average Exercise Prices, Beginning		$ 0.16	$ 0.36
Number of Shares, Options granted				9,592,000
Weighted Average Exercise Prices, Options granted			$ 0.14
Number of Shares, Options exercised				(125,000)
Weighted Average Exercise Prices, Options exercised			$ (0.13)
Number of Shares, Options granted			(500,000)
Weighted Average Exercise Prices, Options granted		$ (0.50)
Number of Shares, Ending		10,242,000	10,742,000	1,275,000
Weighted Average Exercise Prices, Ending		$ 0.15	$ 0.16	$ 0.36
Number of Shares, Exercisable Ending		9,113,528
Weighted Average Exercise Prices, Exercisable Ending		$ 0.15

Common Stock Options (Details N

Common Stock Options (Details Narrative) - USD ($)						12 Months Ended
	Jul. 26, 2021	May 28, 2021	May 25, 2021	Jan. 02, 2021	Feb. 12, 2020	Dec. 31, 2022	Dec. 31, 2021	Jan. 28, 2022	Jan. 01, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares						134,128
Stock based compensation expense						$ 339,133	$ 133,755
Shares issued for options exercised, shares	60,000
Options outstanding	125,000							500,000
Purchase price per share	$ 0.13							$ 0.50
Board of Directors [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock sold for cash, shares					10,000,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares		1,000,000
Options exercise price, per share		$ 0.1782
Options exercisable period		10 years
Stock option, volatility rate		183%
Stock option, call option, price per share		$ 0.1719
Stock option, call option value		$ 171,949
Unamortized expenses							171,949
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options vested during period, shares		500,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options vested during period, shares		500,000
Vahe Gabriel [Member] | 2019 Stock Incentive Plan [Member] | Vesting Two Quarters [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options vested during period, shares		250,000
Three Advisory Board Members [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares			425,000
Options exercise price, per share			$ 0.17
Options exercisable period			10 years
Stock option, volatility rate			183%
Stock option, call option, price per share			$ 0.1653
Stock option, call option value			$ 70,269
Unamortized expenses						14,644
Stock based compensation expense						35,132	20,493
Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares				5,500,000
Options exercise price, per share				$ 0.13					$ 0.13
Options exercisable period				10 years
Stock option, volatility rate				192%
Stock option, call option, price per share				$ 0.1174
Stock option, call option value				$ 645,624
Unamortized expenses						117,383
Stock based compensation expense						$ 117,388	410,853
Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Quarterly [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options vested during period, shares				2,750,000
Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Immediately [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options vested during period, shares				2,750,000
Isiah L Thomas III [Member] | 2019 Stock Incentive Plan [Member] | Vesting Eleven Quarters [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options vested during period, shares				250,000
Dr Ken Perego [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares				350,000
Options exercise price, per share				$ 0.13
Options exercisable period				10 years
Stock option, volatility rate				192%
Stock option, call option, price per share				$ 0.1170
Stock option, call option value				$ 40,943
Unamortized expenses							40,943
Stock based compensation expense							40,943
Bruce Raben [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options exercise price, per share				$ 0.13
Stock option, volatility rate				192%
Stock option, call option, price per share				$ 0.1170
Stock option, call option value							55,565
Number of options awarded during period, shares				475,000
Stock based compensation				$ 55,565
Seven Consultants and Employees [Member] | 2019 Stock Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of options awarded during period, shares				1,842,000
Options exercise price, per share				$ 0.13
Options exercisable period				10 years
Stock option, volatility rate				192%
Stock option, call option, price per share				$ 0.1170
Stock option, call option value				$ 215,475
Stock based compensation							$ 215,475

Schedule of Warrants to Purchas

Schedule of Warrants to Purchase Common Stock Outstanding (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Shares Underlying Warrants Outstanding, Range of Exercise Prices	$ 0.13
Shares Underlying Warrants Outstanding | shares	10,242,000
Shares Underlying Warrants Outstanding, Weighted Average Remaining Contractual Life	8 years 18 days
Shares Underlying Warrants Outstanding, Weighted Average Exercise Price	$ 0.15
Shares Underlying Warrants Exercisable | shares	9,113,528
Shares Underlying Warrants Exercisable, Weighted Average Exercise Price	$ 0.15
Warrant [Member]
Shares Underlying Warrants Outstanding | shares	11,511,650
Shares Underlying Warrants Outstanding, Weighted Average Remaining Contractual Life	2 years 5 months 4 days
Shares Underlying Warrants Exercisable | shares	11,511,650
Warrant [Member] | Minimum [Member]
Shares Underlying Warrants Outstanding, Range of Exercise Prices	$ 0.25
Shares Underlying Warrants Outstanding, Weighted Average Exercise Price	0.25
Shares Underlying Warrants Exercisable, Weighted Average Exercise Price	0.25
Warrant [Member] | Maximum [Member]
Shares Underlying Warrants Outstanding, Range of Exercise Prices	0.50
Shares Underlying Warrants Outstanding, Weighted Average Exercise Price	0.50
Shares Underlying Warrants Exercisable, Weighted Average Exercise Price	$ 0.50

Schedule of Fair value Assumpti

Schedule of Fair value Assumption of Warrants (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Average risk-free interest rates	3.79%	0.47%
Average expected life (in years)	5 years	3 years
Volatility	157%	197%

Schedule of Warrants Activity (

Schedule of Warrants Activity (Details) - Warrant [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Number of Shares, Outstanding	11,011,650	7,511,650
Weighted Average Exercise Price, Outstanding	$ 0.30	$ 0.25
Number of Shares, Warrants granted	500,000	3,500,000
Weighted Average Exercise Price, Warrants granted	$ 0.25	$ 0.39
Number of Shares, Outstanding	11,511,650	11,011,650
Weighted Average Exercise Price, Outstanding	$ 0.29	$ 0.30
Number of Shares, Exercisable		11,511,650
Weighted Average Exercise Price, Exercisable	$ 0.29

Common Stock Warrants (Details

Common Stock Warrants (Details Narrative)	Dec. 21, 2022 USD ($) $ / shares shares	Dec. 20, 2022 USD ($) $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 $ / shares
Warrants purchase			11,511,650
Number of warrants to purchase common stock			3,500,000
Exercise price of warrants | $ / shares			$ 0.29	$ 0.10
Series A Preferred Stock [Member]
Sale of stock	5,000
Series A Preferred Stock [Member] | Warrant [Member]
Proceeds from equity securities | $	$ 50,000
Sale of stock	2,500	2,500
Warrant term	5 years	5 years
Number of warrants to purchase common stock	250,000	250,000
Exercise price of warrants | $ / shares	$ 0.25	$ 0.25
Warrants outstanding value | $	$ 17,468	$ 17,499
Proceeds from sale of stock | $		$ 50,000
Series A Preferred Stock [Member] | Warrant [Member] | Measurement Input, Price Volatility [Member]
Warrants outstanding measurement input	157	157
Series A Preferred Stock [Member] | Warrant [Member] | Measurement Input, Share Price [Member]
Warrants outstanding measurement input | $ / shares	0.0699	0.07

Schedule of Effective Income Ta

Schedule of Effective Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Federal statutory income tax rate	21%	21%
State income taxes
Change in valuation allowance	(21.00%)	(21.00%)
Net effective income tax rate

Schedule of Deferred Tax Asset

Schedule of Deferred Tax Asset (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 1,950,000	$ 1,535,000
Net deferred tax assets before valuation allowance	1,950,000	1,535,000
Less: Valuation allowance	(1,950,000)	(1,535,000)
Net deferred tax assets

Income Tax (Details Narrative)

Income Tax (Details Narrative)	12 Months Ended
	Dec. 31, 2022 USD ($)
Income Tax Disclosure [Abstract]
Federal net operating losses	$ 9,285,000
Net operating loss carry forwards expiration	The net operating loss carry forwards, if not utilized, will begin to expire in 2025

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)					3 Months Ended	12 Months Ended
	Feb. 14, 2023	Jan. 01, 2023	Dec. 21, 2022	Dec. 21, 2022	Apr. 03, 2023	Dec. 31, 2022	Dec. 31, 2021
Subsequent Event [Line Items]
Fair value warrants to purchase						3,500,000
Exercise price of warrants						$ 0.29	$ 0.10
Cash proceeds from issuance of common stock						$ 350,000	$ 3,577,505
Common stock issued for services						$ 134,128	$ 133,755
Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock shares sold	3,000,000
Common stock price per share	$ 0.10
Cash proceeds from issuance of common stock	$ 300,000
Series A Preferred Stock [Member]
Subsequent Event [Line Items]
Common stock shares sold				5,000
Series A Preferred Stock [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Common stock issued for services, shares		4,500
Common stock issued for services		$ 45,000
Series A Preferred Stock [Member] | Preferred Stock Sales [Member]
Subsequent Event [Line Items]
Proceeds from sale of stock			$ 50,000
Common stock shares sold			5,000
Warrant term			5 years	5 years
Fair value warrants to purchase			500,000	500,000
Exercise price of warrants			$ 0.25	$ 0.25
Series A Preferred Stock [Member] | Preferred Stock Sales [Member] | Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from sale of stock					$ 250,000
Common stock shares sold					25,000
Warrant term					5 years
Fair value warrants to purchase					2,500,000
Exercise price of warrants					$ 0.25